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Abstract
The United States health system strives to improve the care patients receive while
reducing healthcare expenditures. A significant portion of the nation’s healthcare expenditure is
spent on end of life care. Palliative care provides one solution to reducing healthcare
expenditures while improving the patient experience. Reducing symptom intensity is one
example of palliative care’s success. A midwest palliative care program was tasked to gather
quality data on the service’s ability to manage patient symptoms.
The program selected the MD Anderson Symptom Inventory to improve symptom
assessment and provide quality metrics for the organization. Additionally, research suggests
rural populations have poorer access to palliative care services compared to non-rural patients.
In response, a qualitative questionnaire was administered to rural and non-rural patients at
consultation to gather information regarding barriers to palliative care services. Finally, the
quality improvement initiative was evaluated for acceptability, feasibility, and sustainability.
The scholarly project provided the organization characteristics of the population served,
accurately assessed symptoms, and tracked performance of symptom management over time.
The implications of this project is the MD Anderson Symptom Inventory provided a sustainable
and feasible plan for a community based palliative care program to generate and gather quality
data. The perceived barrier questionnaire revealed that patients experience symptoms for a long
time prior to a palliative care referral and a knowledge gap exists regarding the role and
existence of palliative care.

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS

6

Executive Summary
A midwest palliative care program was tasked to gather quality data on the service’s
ability to manage patient symptoms. Therefore, the MD Anderson Symptom Inventory
(MDASI) was administered to new home-based palliative care referrals to improve symptom
assessment and provide quality metrics for the organization. Additionally, research suggests
rural populations have poorer access to palliative care services compared to non-rural
populations. In response, a qualitative questionnaire was administered to rural and non-rural
patients at consultation to gather information regarding barriers to palliative care services.
Implementing the MDASI provided characteristics of the patient population’s symptoms
at consultation. The MDASI demonstrated that patients consulted for pain were in significant
distress with an average pain rating of 7.93 out of 10 at consultation. However, patients who
were consulted for pain and had a follow up interaction in 1 week had a mean pain improvement
score of 6. The project design demonstrated that the MDASI is capable of measuring program
effectiveness in managing symptoms over time. Upon evaluation of the scholarly project, it was
learned that implementing the MDASI at consultation, 1 week after consultation, and 1 month
after consultation was acceptable, feasible, and sustainable for the organization.
Immediately following the administration of the MDASI, 4 short answer questions were
posed to patients during the consultation phone call. The 4 questions were analyzed for themes
and patterns. Responses to the 4 short answer questions revealed that patients experience
symptoms for long durations of time prior to receiving a palliative care referral. Additionally,
patients reported a number of barriers to palliative care services. The most frequently reported
barrier was a lack of knowledge of the existence and role of palliative care. In all, 17 of 25
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patients did not receive palliative care sooner because of a knowledge gap. Of these 17 patients,
15 responded identically by saying, “I didn’t know about it.”
Patients learned about palliative care most frequently from a primary care provider
(PCP). Specifically, 9 of the 25 patients learned about palliative care from a PCP. An analysis
of co-occurrences deduced that 4 of the 5 patients that reported symptom duration in years
learned about palliative care from a PCP. Oncologists were the second most frequent source of
palliative care knowledge, educating 4 patients. Lastly, all patients responded, “no” when asked,
“Do you believe where you live impacted your ability to receive palliative care?”
The qualitative analysis of patient perceived barriers to palliative care is consistent with
the concerns already described in literature. Patients in both rural and non-rural communities
suffer from unrelieved symptoms for long durations of time prior to receiving palliative care.
The qualitative analysis was also consistent with literature that suggests a knowledge gap in rural
and non-rural communities. Although this knowledge is not new, it validates the need for
improved widespread education of palliative care’s existence and role.
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Acceptability of the MD Anderson Symptom Inventory and qualitative analysis of barriers to
palliative care services for rural and non-rural populations
The goal of current healthcare reform known as the triple aim is to improve the health of
populations, reduce cost, and improve the patient experience through quality care and improved
patient satisfaction (Berwick, Nolan, & Whittington, 2008). The United States spends more
money on healthcare than any other country yet our health outcomes are inferior to most
developed countries (Bharadwaj et al., 2016). Moreover, in the United States there is a
significant disparity in the allocation of healthcare resources among the population. In fact, in
the United States two thirds of the nation’s healthcare expenditures are spent on just 5-10% of
the population. This disproportionate utilization of limited healthcare resources is largely
accrued during end of life. Although only 5% of patients with Medicare die each year, end of
life care accounts for roughly 25% of Medicare expenditures (Riley & Lubitz, 2010).
Background and Significance
Almost one quarter of seniors live with at least 4 chronic medical conditions (Chen et al.,
2015). The final stage of life in patients with chronic conditions is often characterized by heavy
and aggressive healthcare utilization. However, research demonstrates that aggressive medical
interventions in the final weeks of a patient’s life such as emergency department visits,
hospitalizations, intensive care unit admissions, and chemotherapy administration are all
associated with poor quality of life, poor quality of death, and perceived poor quality of end of
life care by caregivers (Higgins, Garrido, & Prigerson, 2015; Hui et al., 2014). Palliative care
can address this issue by providing guidance to patients and families to choose appropriate
therapies that coincide with a patient’s goals and wishes.
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Palliative care is an interprofessional discipline that focuses on quality of life for patients
with a life limiting illness by managing symptoms, facilitating communication, and guiding
patients through medical decision-making (Hui et al., 2014). Quality palliative care is associated
with reduced symptom burden, improved quality of life, increased patient and family
satisfaction, cost avoidance, and reduced hospitalizations (Kerr, Tangeman, et al., 2014).
Hospital systems have adopted palliative care programs in order to improve quality indicators
and reduce costs. More recently, new recommendations encourage hospital systems to build and
implement community based palliative care programs as an effort to involve palliative care
earlier in a patient’s experience with a life limiting illness (Kerr, Tangeman, et al., 2014). Earlier
palliative care engagement guides proactive rather than reactive decision-making, assessment
and treatment of distressing symptoms sooner, and improves quality of life. In fact, an outpatient
palliative care referral has been observed as an independent factor for improved end of life care
(Hui et al., 2014).
Problem Statement
According to a comprehensive organizational assessment, a midwest community based
hospice and palliative care program had a strong desire to gather metrics of program
performance in order to evaluate the organization’s progress towards achieving the mission and
vision. The purpose of this project was to implement and evaluate an evidence-based symptom
inventory tool in a community based palliative care program.
Community based palliative care teams are known to reduce cost and improve quality of
life by managing distressing symptoms (Brumley et al., 2007). These services however are
unavailable to many rural communities (M. A. Bakitas et al., 2015). In this project, the patient
population was divided between rural and non-rural areas. To investigate this concern,
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additional focused assessment on the differences between rural and non-rural palliative care
patients was completed to procure insights regarding perceived barriers to accessing palliative
care services.
The Theory of Distressing Symptoms was used as a theoretical framework to guide the
selection and implementation of the symptom inventory tool. Short answer questions were
formulated to inquire about patient knowledge of palliative care services, establish the duration
of time the patient experienced symptoms prior to referral, determine perceived barriers to
accessing services, and perceptions of how demographics may impact access to services.
Finally, the organization’s acceptance of the implementation was measured through staff
questionnaires.
The evidence for the chosen tool and a plan for implementation and evaluation was
outlined and discussed. The Theory of Unpleasant Symptoms guided conceptualization of the
symptom experience and the PARiHS model directed implementation of the quality
improvement project. Finally, the project describes stakeholder support, presents a plan for
project sustainability, examines the results and implications for practice, and outlines how
outcomes will be disseminated. The examination of literature begins with a discussion of the
Symptom Science movement because of Symptom Science’s mission to expand symptom
knowledge.
Symptom Science
The Symptom Science Model was created by the National Institute of Nursing Research
to direct biobehavioral research, improve symptom management, and study tissue injury (Henly,
2015). The Symptom Science Model guides the description of complex symptoms, phenotypic
characterization, and biomarker discovery for clinical application. The goal of this model is to
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expand the understanding of symptoms and symptom management to improve outcomes and
health-related quality of life (Cashion & Grady, 2015). The Symptom Science Model was
created to make symptom research meaningful. Symptom Science researchers hope to further
understand symptom clusters and the trajectory of distressing symptoms over time by forming
interdisciplinary teams and encouraging cohesive methodology (Dodd et al., 2001).
Symptom assessment and symptom management is central to the role of nursing (Corwin
et al., 2014). Nurses are well educated and are in an ideal position to analyze symptom triggers,
reduce severity, and improve the symptom experience. However, the field of symptom science
faces many challenges (Henly, 2015). Symptom research is challenging because it is difficult to
generalize and compare across populations and research studies (Dodd et al., 2001). Moreover,
literature on symptom management utilizes up to 47 different symptom measurement tools
(Paice, 2004). The array of tools often measure different symptom clusters and use a variety of
different scaling techniques. After addressing the problem of gathering quality and cohesive
data, the final challenge identified by the Symptom Science researchers is knowledge
dissemination. It is essential to expand understanding of the symptom experience to improve the
care offered to suffering populations.
Symptom impact on health
Unrelieved symptoms significantly impact a patient’s quality of life and ability to
function (Cleeland et al., 2000). Unpleasant symptoms profoundly alters and limits activities,
negatively impacts family relationships, impairs work productivity, and decreases quality of life
(Dodd et al., 2001). Symptoms can also lead to the feeling of sadness, fear, vulnerability, and
cause profound distress (Carlson, Waller, & Mitchell, 2012). For example, researchers suggest
that unrelenting pain can lead to depression, anxiety, panic, social isolation, and spiritual crisis.
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Unpleasant symptoms contribute to distress and are a major detriment to quality of life and
functional ability (Cleeland et al., 2000).
A large symptom burden leads to poor quality of life in patients with a life-limiting
illness. In 2016, there were approximately 14.5 million Americans fighting cancer (National
Cancer Institute, 2016). Symptomology literature over the last decade consistently reports a high
prevalence of symptoms in cancer patients in tertiary care, hospice, and community settings (V.
T. Chang, Hwang, Feuerman, & Kasimis, 2000). Patients undergoing cancer treatment are
known to report an average of 11 to 13 concurrent symptoms (Fan, Filipczak, & Chow, 2007).
Researchers conducting a study in a Veterans Affairs hospital also reported a complex symptom
experience, describing a median of 8 concurrent symptoms among cancer patients (V. T. Chang
et al., 2000). The most consistent symptoms reported and identified were pain, fatigue, dry
mouth, shortness of breath, and difficulty sleeping. Moreover, in these studies pain was never a
solitary symptom. In fact, patients experiencing intense fatigue and pain were most likely to
experience a multitude of other symptoms as well. Pain and fatigue were closely tied to the
symptoms of dry mouth, dyspnea, fatigue, and weight loss (V. T. Chang et al., 2000).
Cancer and heart failure are the 2 most frequently represented diseases within the field of
palliative care. Over 5 million Americans are diagnosed with chronic heart failure with a yearly
incidence of at least 500,000 (Go et al., 2014). Like cancer, persons with end stage heart failure
also have a high symptom burden (Adler, Goldfinger, Kalman, Park, & Meier, 2009). Patients
with heart failure endure a mean of 9 symptoms concurrently. The most common symptom
clusters noted in heart failure research are shortness of breath, fatigue, pain, drowsiness, and dry
mouth (Bekelman et al., 2007). Heart failure may also lead to significant psychological,
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physical, and economic burden. Thus there is a tremendous need for community based palliative
care to relieve suffering and improve quality of life in this population.
Community Based Palliative Care Programs
Distressing symptoms are the most common reason patients seek healthcare (Xiao, 2010).
Palliative care services significantly reduce unpleasant symptoms in patients with a life limiting
illness (Bharadwaj et al., 2016). The initiation of palliative care within 48 hours of a hospital
admission has been shown to decrease hospital length of stay by roughly 5 days, reduce overall
hospital costs by as much as 40%, and has an insignificant impact on mortality rates. According
to Bharadwaj et al. (2016) readmission rates are also significantly reduced at 30, 60, and 90 days
following hospital discharge if palliative care is consulted early in a hospital stay. In addition,
patients may require a hospital readmission and undergo unnecessary suffering (Chen et al.,
2015). Hospital readmissions cause further distress and life interruption for both patients and
caregivers.
Hospital readmissions are traumatizing to patients and are expensive and burdensome for
the healthcare system. Financial penalties continue to climb for institutions with high
readmission rates to provide incentives to improve care and reduce readmissions (Kripalani,
Theobald, Anctil, & Vasilevskis, 2014). Moreover, readmissions cost the United States
healthcare system 17.4 billion dollars annually in Medicare expenditures alone. Over one
quarter of patients readmitted within 30 days of discharge are patients with heart failure. To
address this issue research attempted to determine which interventions could reduce hospital
readmissions for high-risk patients. Timely follow-up, medication reconciliation, patient
education, home visits, and patient centered discharge instructions are interventions that
significantly reduced hospital readmissions. All of these interventions improve the patient
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experience and are at the core of community based palliative care services (Kerr, Tangeman, et
al., 2014).
Outpatient palliative care services reduce hospitalizations and increase hospice
utilization, which further reduces healthcare costs and improves quality care at the end of life
(Blackhall et al., 2016). Kerr et al. (2014) found that an outpatient palliative care referral
increased hospice admission by 45% as compared to a control group and increased the duration
of hospice services by 25 days. In the same study, patients with an outpatient palliative care
referral utilized fewer healthcare resources and saved an average of 11,724 dollars in the last 3
months of life. The cost of care for the treatment group in the final week of life was half of that
for the control group. Increased hospice utilization is important for cost avoidance but it is also
important for quality care (Higgins et al., 2015). Hospice focuses on preventing and relieving
symptoms and prepares family and patient for the time near death (Lynn, 2001). According to
Higgins et al. (2015) the duration of hospice care and location of death are the most significant
factors for patient caregiver’s perceived quality of end of life care. Hospice admissions within a
week of a patient’s death is associated with poor caregiver perceived quality of end of life care
and can often be avoided with early outpatient palliative care involvement.
A primary objective of palliative care is the discussion, documentation, and fulfillment of
advanced directives. In fact, patients receiving community based palliative care are 3 times more
likely to complete advanced directives (Chen et al., 2015). Although hospice benefits have been
a Medicare approved service for over 3 decades, hospice continues to be underutilized or
initiated too late (Brumley et al., 2007). In 2007, 60% of deaths occurred in the hospital despite
the fact that most patients wish to die at home (Brumley et al., 2007). In one study, improved
advanced care planning with community based palliative care resulted in a reduction of hospital
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admissions by 59% and shorter lengths of stay by over 5 days per patient (Chen et al., 2015).
One hospital implemented an automatic palliative care referral system that triggered referrals for
patients that were admitted with a life limiting illness. The hospital found that the automatic
referral system significantly reduced aggressive end of life treatment and improved patient
satisfaction (Maltoni et al., 2016). This research is consistent with other literature that
demonstrates reduced aggressive end of life treatment improves perceived quality of end of life
care (Higgins et al., 2015; Maltoni et al., 2016). Community based palliative care increases
patient satisfaction, increases likelihood of dying at home, reduces overall cost of care, and
promotes the fulfillment of healthcare end of life wishes (Brumley et al., 2007).
Oncology patients are the largest population of patients that utilize palliative care
services. As cancer treatment has improved over time, the perception of cancer has changed:
more recently cancer has become viewed as a chronic illness that is predominantly managed in
the ambulatory setting. Therefore, the most ideal setting to provide palliative care for oncology
patients is in the outpatient setting (Hui et al., 2014).
It is valuable to note that symptom burden, in both number and severity of symptoms is
not related to the extent of one’s disease (V. T. Chang et al., 2000). Therefore, patients with less
advanced cancer in the outpatient setting may suffer from a similar symptom burden as those
hospitalized for an advanced disease. Oncology patients in the outpatient setting may experience
a multitude of symptoms that can be quickly resolved by palliative care engagement.
The impact of palliative care can be measured and identified quickly following a
consultation. In one study, outpatient palliative care improved the patient’s symptom experience
within the first week of a palliative care consultation (Follwell et al., 2009). Palliative care
services provided a 10% symptom reduction compared to baseline within the first week of
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palliative care initiation. With continued palliative care involvement these results were sustained
at 1 month. Patient satisfaction was significantly higher in the palliative care treatment group
compared to the control group at 1 week and 1 month after the palliative care consultation.
Symptom reduction is important for quality of life but it may also be important to
continue with treatment. Peripheral neuropathy, fatigue, intractable pain, and intractable nausea
are all symptoms that can delay, halt, or result in dose reductions of chemotherapy or radiation.
Changing treatment course may be necessary but can impact effectiveness of therapy, which can
be fatal (J. Chang, 2000). Improving distressing symptoms that result in treatment delay or dose
reduction is imperative to proceed with preferred treatment regimens.
Although, cancer and its treatment are distressing, palliative care can help reduce
treatment distress. Rummans et. al (2006) studied quality of life in a cohort of patients
undergoing radiation therapy for cancer. Quality of life was measured prior to and following
radiation for a control group and a multidisciplinary treatment group. The multidisciplinary
group included palliative care services. During the study, the control group had significantly
poorer quality of life scores after radiation compared to baseline scores. After radiation, the
multidisciplinary treatment group showed improved quality of life scores compared to the
control group and compared to baseline (Rummans et al., 2006). This evidence suggests that
quality of life can be sustained or even improved while undergoing cancer treatment with the
involvement of a palliative care team and a multidisciplinary treatment approach. Palliative care
services improve quality of life and should be available to all populations (M. Bakitas et al.,
2009; Brumley et al., 2007; Hui et al., 2014).
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Rural Populations
Rural areas are home to roughly 70 million Americans accounting for 23% of the United
States population (Befort, Nazir, & Perri, 2012). Evidence suggests there is a disparity between
rural and non-rural populations in referral and access to palliative care services (M. A. Bakitas et
al., 2015). Patients residing in the rural setting have different demographics, perspectives on
health, and social structures than those in urban settings. Rural populations are more likely to be
older, less educated, poor, and diagnosed with cancer at a later stage (Hughes, Ingleton, Noble,
& Clark, 2004). According to Hughes et al. (2004) rural patients typically have a different
perspective on health and wellbeing. These patients are more likely to view health as the
capability of being self-reliant with the ability to work. The culture of rural populations
combined with poor access to healthcare services impacts the way rural populations view
disease, life, and death.
Rural areas frequently have limited healthcare resources (M. A. Bakitas et al., 2015).
Many rural hospitals lack palliative care programs and have little to no community-based
services. Patients with cancer and other life limiting illnesses in rural areas may be unaware of
services such as palliative care and may not have access to education regarding palliative care
services. Evidence suggests that palliative care services are equally effective in reducing health
care costs and promoting quality of life in rural areas as urban (M. A. Bakitas et al., 2015). Yet
rural communities continue to be underserved.
Simply reproducing urban palliative care models may not translate into the rural setting.
Researchers believe that palliative care implementation in rural areas may require unique
implementation and practice models due to the unique challenges facing these programs. Rural
community based palliative care programs often have scarce resources, a shortage of certified
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palliative care practitioners, and small patient volumes (Ceronsky, Shearer, Weng, Hopkins, &
McKinley, 2013). Additionally, researchers describe a knowledge gap regarding palliative care
services in patients, providers, and communities (Hughes et al., 2004). Large stakeholder
investment from rural communities and health settings will be essential to develop and
implement new rural specific palliative care models in order for community based palliative care
to become a reality in rural communities.
The caregiver structure is often different within rural populations as well (Hughes et al.,
2004). Rural patients are more likely to receive care from a spouse because rural populations are
more likely to be married than non-rural populations (Glasgow, 2000). Among informal
caregivers, children are next in importance in providing care for parents. Although rural
populations produce more children than non-rural it appears rural populations have less physical
access to those children. Rural populations have less access to offspring and other young people
because of the increased geographic mobility among young populations (Glasgow, 2000).
Because of this phenomenon older people living in rural communities are more likely to receive
non-kin assistance from other elders than older people in urban communities. Overall, older
rural residents have stronger informal social support networks and receive more informal
caregiving than urban populations. The differences in social structure and caregiving are
important to identify when studying rural populations and potential barriers to accessing
palliative care.
Common themes were discovered during the literature review of rural patients’ access to
palliative care services. Researchers report that patients residing in rural areas have less access
to palliative care services than those residing in urban settings (M. A. Bakitas et al., 2015). Rural
patients are referred to palliative care later than urban patients and spend more time with
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unrelieved symptoms prior to attaining services. Ceronsky et al. (2013) and Hughes et al. (2004)
have proposed that rural patients do not receive palliative care services in a timely manner due to
scarce rural resources, lack of palliative care models specific for rural communities, lack of
certified rural palliative care practitioners, poor sustainability of programs due to small patient
volumes, and because of a knowledge gap of palliative care services in patients and
communities. External barriers have been studied but little literature exists on patient perceived
barriers to palliative care. It would be advantageous to learn how patients in the region of
interest are learning about palliative care services, determine perceived barriers to services, and
if patients believe region of residence influences access to palliative care. The community based
palliative care team is missioned to improve the quality of life of patients with a life limiting
illness in the region. The knowledge gap that exists in the region and nation is limiting palliative
care from reaching patients who would benefit from thorough symptom assessment and effective
treatment regimens. However, the symptom experience is complex and challenging to measure
(Henly, 2015).
Measuring Symptoms
The study and description of complex symptoms and symptom clusters has long been a
focus of nursing science (Henly, 2015). Despite current technological advances in symptom
management, little has been done to improve symptom measurement (Dodd et al., 2001). A gold
standard to measure the patient symptom experience does not exist. So as a result, measuring the
subjective symptom experience is challenging, and continuing to seek an accurate and thorough
symptom assessment is crucial to provide high quality care. Inconsistent and inadequate
symptom assessments lead to unrelieved symptoms, which decreases quality of life and impairs
physical function (Cleeland et al., 2000). Symptoms impact functional capacity and also can
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interrupt treatment if severe enough. Thus, symptoms must be assessed accurately and
frequently.
Symptom researchers believe that many symptoms are not adequately identified or
treated (Cleeland et al., 2000). Due to the subjective nature of distressing symptoms many
providers under appreciate patient’s symptom burdens. Some assert that oncologists and
healthcare professionals do not proactively assess symptoms and wait until symptoms are
spontaneously reported (Kerr, Tangeman, et al., 2014). Many providers believe that patients will
voluntarily report symptoms if they are truly distressing. However, patients often hesitate to
report symptoms until severe and require emergency department evaluation or hospitalization
(Kerr, Donohue, et al., 2014). Patients also under report symptoms because they want to be a
“good” patient, are resistant to taking additional medications, or have difficulty admitting the
disease may be progressing. Many patients do not want to bother providers and family members.
Chang et al. (2000) claims patients may assume the provider already knows when the patient
experiences symptoms and that reporting is unnecessary. These significant barriers underline the
importance of a comprehensive symptom assessment tool and consistent follow up by providers
(V. T. Chang et al., 2000).
Measuring What Matters
The American Academy of Hospice and Palliative Medicine and the Hospice and
Palliative Nurses Association recently began a project to identify the most important quality
measures in palliative care and hospice (Dy et al., 2015). With the goal to improve quality of life
for patients undergoing treatment for a serious illness, the Measuring What Matters (MWM)
project selected a set of measures proven to impact quality of care. The MWM team comprised
of nurses and physicians and was able to identify 75 published measures relevant to hospice and
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palliative care. The MWM project achieved consensus on 10 recommended measures which
included: 1) comprehensive assessment; 2) screening for shortness of breath and development of
a management plan; 3) screening for pain and providing treatment within 24 hours; 4) screening
for nausea and constipation during initial consultation; 5) documentation of a discussion
regarding psychological and emotional needs; 6) documentation of a discussion of spiritual needs
and concerns; 7) completing documentation of surrogate decision makers; 8) documentation of a
discussion regarding preferences for life sustaining treatments; 9) completion of the necessary
documentation regarding end of life preferences for vulnerable elders; and 10) surveying patient
and family satisfaction. The MWM project created a foundation to evaluate hospice and
palliative care programs and established standards to promote program accountability.
Assessment tools assist programs in measuring what is important. In the next sections a variety
of measurement tools are discussed.
Assessment Tools
A good symptom inventory is important to improve early symptom detection and
treatment. Providers need a tool that can identify symptoms, determine severity, and that is
sensitive enough to detect a response to treatment or changes in health (Cleeland et al., 2000). In
conducting a systematic review of instruments, Paice et al. (2004) found 47 pain, symptom, and
palliative care tools but reported that none were ideal. Creating a perfect symptom assessment
tool is challenging due to the complexity and variety of symptoms a patient may experience.
Making matters more challenging, symptom experiences are specific to the disease and
individual. What may be an ideal symptom assessment tool for one palliative care patient may
not be applicable to another. In the next sections, several common symptom inventories are
discussed with their relative benefits and limitations.
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Palliative Outcome Scale
The POS was developed to measure palliative care outcomes as a whole rather than by
symptom management. The goal of the POS is to create higher standards of care by determining
if patient and family needs are being addressed effectively and efficiently (Hearn & Higginson,
1999). According to the creators of the POS, it provides an efficient measurement tool designed
to meet the need for a short and easy assessment of palliative care core quality measures. The
POS consists of 10 Likert scale questions and 2 short answer opportunities. The symptoms
measured include pain, nausea, coughing, constipation, anxiety, and psychosocial components.
In addition to symptom measures, the POS poses questions regarding goals of care discussions
and whether the patient feels needs are being addressed. The POS is validated and reliable for
hospice and palliative care in the inpatient and outpatient setting (Hearn & Higginson, 1999).
The POS is the most well rounded palliative outcome scale that meets most of the MWM
project points of focus. This assessment may be helpful in evaluating patient care but is not
applicable at consultation. The scale takes roughly 8 minutes to complete but may require
frequent clarification. Additional concerns regarding the POS are the questionable
responsiveness to treatment and the low Cronbach’s alpha score of 0.65 suggesting poor internal
consistency (Paice, 2004). The POS measures a program’s overall performance but is less
effective in measuring a program’s ability to manage patients’ symptoms.
M.D. Anderson Symptom Inventory
The MD Anderson Symptom Inventory (MDASI) was created specifically for the
oncology population. The MDASI measures the severity of 13 symptoms and 6 interference
items on an 11-point scale (Cleeland et al., 2000). The tool measures pain, fatigue, nausea,
disturbed sleep, distress, shortness of breath, remembering, appetite, drowsiness, dry mouth,
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sadness, vomiting, and numbness or tingling. The interference items ask the patient how much
the symptoms interfere with the patient’s general activity, mood, ability to work around the
house, relationships, walking, and enjoyment of life. The average completion time of the
questionnaire is 5 minutes. The MDASI was created and validated to be administered over the
phone or via interactive voice response. The tool is also psychometrically validated in 7
different languages. The test-retest coefficient for the MDASI is 0.75-0.96 and has been
validated within the cancer population with a Cronbach’s alpha of 0.85 to measure symptoms
and 0.93 in the interference items (Paice, 2004).
The MDASI has been validated time and time again with a variety of cancer diagnoses
(Cleeland et al., 2000) but the MDASI has not been specifically validated within the broad and
expanding palliative care field. However, the symptom clusters of the MDASI are similar to
those in the Edmonton Symptom Assessment Scale (ESAS) and other validated palliative care
assessment tools (Paice, 2004). Additionally, the MDASI has a large operational and
implementation advantage in that it can be administered and validated over the phone or through
automated interactive voice response (Cleeland et al., 2000).
Cancer treatment guidelines recommend the regular assessment of the influence of pain
on activities such as work, sleep, and social interactions (Cleeland et al., 2000). The interference
items on the MDASI meet this guideline and were a significant contributor to the selection of the
MDASI for implementation. The midwest palliative care team chose the MDASI as the
symptom inventory of choice for this implementation project because of the ability of the tool to
measure symptom clusters, the addition of the interference items, and the validation of
administration over the phone.
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Frequency of Administration
To determine frequency of MDASI administration for the project design a brief literature
review was conducted. Upon review, there are no explicit recommendations for reassessment of
symptoms in palliative care follow-up. There are however general guidelines for a variety of
different patient populations. The Center for Disease Control and Prevention (CDC)
recommends monitoring patients receiving chronic opioid therapy every 3 months (Dowell D,
Haegerich TM, & Chou R, 2016). High-risk non-cancer patients receiving chronic opioid
therapy should receive follow-up as often as weekly (Chou et al., 2009). All patients with cancer
should be screened for pain and distressing symptoms at each point of contact (Ripamonti,
Santini, Maranzano, Berti, & Roila, 2012). Measuring and identifying pain regularly is essential
to effectively manage cancer pain. The exact symptom assessment intervals however, depend on
severity of symptoms and patient setting (Walsh et al., 2008). Patients residing in the outpatient
setting may require follow up by phone. Specific follow up recommendations do not exist for
this population. However, theories are available to guide conceptualization of unpleasant
symptoms to deepen the understanding of this phenomenon.
Theory of Unpleasant Symptoms
The Theory of Unpleasant Symptoms (TOUS) is a middle ranged theory intended for
application by nurses and clinical researchers (Peterson & Bredow, 2009). The TOUS was the
first symptom theory to describe multiple symptoms occurring simultaneously and to depict an
interaction between them. The TOUS asserts that symptoms potentiate and catalyze one another
and the treatment of one symptom will contribute to the management of another. The TOUS is a
theoretical framework used to guide studies of patient’s symptom experience. The framework
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has been used to study symptoms associated with a variety of illnesses including cancers, chronic
obstructive pulmonary disease, heart failure, transplant surgeries, and the postpartum period.
The Theory of Unpleasant Symptoms depicts antecedent factors, the symptoms
themselves, and symptoms’ impact on performance. In the TOUS, symptoms do not occur in a
vacuum. The authors are aware that a patient’s situation, environment, demographics, psyche,
and physiology all impact the symptom experience. These influencing factors or antecedent
factors are conceptualized into 3 categories: physiological factors, psychological factors, and
situational factors. Each symptom is measured in multiple dimensions. The dimensions
measured include duration, intensity, distress, and quality. The framework illustrates the
interaction of symptoms in a stacked configuration. The final concept in the TOUS is
performance. Lenz et al. (1997) asserts that symptoms affect performance and in turn
performance influences symptoms and the antecedent factors. Appendix A presents a depiction
of the theory’s conceptual model.
The TOUS can be applied to rural populations. Rural populations have different social
and physical environments (M. A. Bakitas et al., 2015). Rural populations also have different
physiological characteristics. Specifically, rural populations are more likely to be diagnosed at
an advanced stage of disease, more likely to be older, and often have different perceptions of
health and illness (Hughes et al., 2004). Rural populations may also have unique antecedent
factors and, according to the TOUS, different factors impact the symptom experience. The
formation of questions posed to rural populations is guided by the antecedent factors depicted in
the TOUS.
The MDASI was created to measure common symptom clusters that occur concurrently
(Cleeland et al., 2000). Cleeland et al. (2000) asserts that multiple symptoms have a cumulative
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effect on one another and on performance. Consistent with the TOUS, this author also
emphasizes the importance of assessing multiple symptoms simultaneously to reduce patient
distress. The symptom inventory assesses multiple symptoms on a 0-10 scale to assess intensity.
The MDASI also assesses distress and performance through the interference items. However,
the MDASI does not measure duration or quality of symptoms.
In summary, the MDASI is consistent with the concepts in the TOUS and serves as a
sound measurement tool to measure multiple concurrent symptoms and the impact of symptoms
on performance. A middle range theory has guided conceptualization of this project, a literature
review was conducted to understand barriers to symptom assessment in those with life limiting
illness, and the MDASI has been chosen to measure symptoms. The implementation model
utilized to guide and support the implementation process will be discussed next.
PARiHS Implementation Model
The Promoting Action on Research Implementation in Health Services (PARiHS)
implementation framework is a useful and practical guide for the implementation of evidence
based practice (Rycroft-Malone, 2004). The PARiHS framework was created within the Royal
College of Nursing Institute in the United Kingdom as an attempt to portray the complexity of
change processes when implementing research based evidence into practice. The key factors
within the PARiHS framework are evidence, context, and facilitation (Rycroft-Malone, 2004).
Each factor in the framework is on a high or low continuum. Using the PARiHS framework and
a variety of implementation attempts, Rycroft-Malone et al. (2004) assert that in order for
implementation to be successful there must be clarity regarding the nature of evidence, a quality
context, and skilled internal and external facilitation. The most successful implementations
occur when scientific support is strong, the implementation contributes to patient satisfaction,
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and when the professional team agrees on implementation strategies. Other factors consistent
with successful implementation include strong leadership, a context receptive to change, and the
presence of feedback systems with accountability.
Evidence
Evidence is “knowledge derived from a variety of sources that has been subjected to
testing and has been found to be credible” (Rycroft-Malone, 2004, p. 311). Within the PARiHS
framework evidence is not merely research driven, evidence also entails clinical and patient
experience. There is considerable evidence of the importance of a consistent assessment of
symptoms using a standard and validated measure within the palliative care population (Paiva et
al., 2014). In existing research, consistent symptom assessment has a significant impact on
patient experience and quality indicators (Paiva et al., 2014). The providers at the midwest
palliative care program were aware of the importance of frequent and consistent symptom
measurement; however, the previous clinical experience with administering instruments and
gathering quality measures had been inconsistent. The providers had a negative clinical
experience with measurements; viewing previous implementations as cumbersome and
interruptive.
In summary, the evidence for the implementation project was high. The literature review
was also consistent on the impact of frequent symptom assessment using a standard
measurement tool on quality of care and on the patient experience (Paiva et al., 2014). However,
the personal clinical experience of evidence was low. Overall, the evidence for the
implementation project was moderate to high.
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Context
Context refers to the environment in which the implementation is taking place.
Contextual factors include the organization’s culture, leadership, and evaluation. The midwest
hospice and palliative care organization had a culture that was accepting of change especially
when change might lead to actualization of the organization’s vision. The organization
underwent radical changes over the previous 5 years, increased patient census, and became
fiscally sustainable as a result. The organization experienced and survived this change because
of strong leadership. The leadership was supportive of the implementation process and was
willing to contribute the necessary resources to sustain the project following the doctoral
student’s involvement. Evaluation was achieved both internally and externally. Internal
evaluation occurred as the symptom inventory established a measure for provider effectiveness.
The implementation of the MDASI allowed the organization to track symptoms and determine
the effectiveness of symptom treatment regimens. Additionally, providers and organizational
leadership evaluated provider based effectiveness in order to identify areas of opportunity for
education. External evaluations included invested community stakeholders and may support
government accountability in the future. The organization desired quality measures to present to
donors, invested community stakeholders, and third party payers. The context of implementation
in the palliative care program was high due to the positive culture of change, strong leadership,
and internal and external evaluation.
Facilitation
Facilitation is a technique in which a person guides implementation and makes the
implementation process easier for others. The facilitator’s knowledge and skills play a key role
in impacting the context. The facilitator’s role is to help and support implementation by
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providing advice, coordinating efforts between members of the healthcare team, and encouraging
others to think critically to assess the achievement of goals. In this quality improvement project
the doctoral student was the facilitator of the implementation of the project. The key functions
of the facilitator role was to be the expert on the topic, to design evidence-based processes, to
guide implementation, to evaluate effectiveness of implementation, and to impress the
importance of continuing the project following student involvement. Thus there was significant
investment of the facilitator for implementation of the project, and there was motivation for the
facilitator to achieve the unified objectives.
Organizational Assessment
Organizational change is a type of chaos (Gleick, 1988). Systems alone are complex but
change becomes even more complicated when humans are involved (Burke & Litwin, 1992).
However, consistent patterns exist to draw conclusions, make predictions, and guide change
within human systems. The Burke-Litwin Model was created through sound theory and research
to evaluate organizations considering large changes. This model attempts to portray primary
variables and the connecting linkages that should be considered when undergoing organizational
change.
The Burke-Litwin Model of Organizational Change was used to guide research and
interviews with members of the midwest palliative care program. The Burke-Litwin model
predicts organizational performance and its capacity for change (Armenakis & Bedeian, 1999).
This model focuses on organizational conditions and how elements of change impact different
organizational variables. Appendix C depicts the model and shows the relationship between 12
organizational variables. Variables in the Burke-Litwin model include: external environment;
mission and strategy; leadership; organizational culture; structure; management practices;
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systems (policies and procedures); work unit climate; task and independent skills; motivation;
individual needs and values; and individual and organizational performance. The relationships
depicted in the model are either transformational or transactional. Transformational change most
often occurs though interactions with environment forces. Transformational change requires
behavioral and cultural change of the individuals and of the organization as a whole.
Transactional change occurs through short-term interactions between people and groups and
often includes an exchange of information or services.
Burke-Litwin Assessment
The Burke-Litwin Model of Organizational Change was selected to assess the midwest
hospice and palliative care team due to the model’s ability to assess organizational performance,
need for change, and capacity for change. The organization previously attempted to implement
symptom inventory quality measures without success. The Burke-Litwin model was used to
understand why previous implementation failed and how the organization managed change. The
organizational assessment was completed through interviews with the Executive Director,
Director of Business Development, Director of Quality and Education, Registered Nurse, and the
Medical Director. The assessment of the organization begins by studying the external
environment.
External Environment
According to Burke and Litwin (1992) the external environment is the most pivotal factor
of organizational change. The external environment is the conditions and situations outside the
organization’s walls that impact function, vision, and performance. In the region alone there
were 16 organizations that provided palliative and hospice care. According to the director of
business, the palliative care and hospice field became dense and competitive in the geographical
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area with non-profit organizations and for-profit organizations fighting for patients. At times the
competition was not friendly. The organization could not be sustained without an adequate
census of patients. Therefore, the intense competition impacted marketing strategies and overall
functioning of the organization.
According to the Director of Business, stand-alone community-based palliative care
programs were not easily sustainable under the current CMS reimbursement policies because
programs are only reimbursed for consultations. Additionally, it was anticipated that
reimbursement would continue to decline 1 to 1.5 percent in the next few years. The only
financially advantageous feature of the palliative care program was a strategy to retain patients
during their transition into the organization’s hospice program.
The Hospice organization’s geographical location in the midwest significantly impacted
the organization’s success. The people within the organization’s region are known for their
generosity and willingness to financially support organizations that benefit the community. The
hospice and palliative care organization receives substantial donations every year to grow their
budget and meet expenses. Without this generous financial community support, the organization
would not be so financially secure.
The midwest palliative care program provided care within different facilities. The
program served small community hospitals, assisted living facilities, and skilled nursing
facilities. Each of these facilities had different policies, procedures, structure, culture, and
climate. Whenever the organization’s providers entered different healthcare systems, the
providers had to adapt to the facility’s expectations and requirements. It was necessary for the
providers to adapt to new rules, documentation, understand chains of command, and
communicate appropriately and effectively to best meet patient and organizational needs.
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Working in different systems also mandated varying credentialing requirements. Therefore, each
healthcare team member was credentialed to the highest level possible in order to meet the needs
of each facility. The relationships with outside facilities were vital and the midwest hospice and
palliative care organization devoted significant time and resources to continue forming and
strengthening professional ties.
Mission and Strategy
Evidence suggests merely having a written mission statement is important to
organizational effectiveness (Burke & Litwin, 1992). The declared mission states what is
important to an organization and the strategy outlines how to fulfill the organization’s mission
and purpose. The Burke-Litwin model not only assesses the mission and strategy of an
organization, but also assesses the employee’s perception of these statements.
The midwest hospice organization’s mission was to, “provide the most compassionate
and highest quality end-of-life care through physical, emotional, and spiritual support.” The
vision was, “by delivering the highest quality of care for living, [the organization] is recognized
as the most successful, preeminent hospice in [the state].” The organization’s core values were
“a passionate belief in: excellence, honest and integrity, sacredness of human life, and the unique
contribution of each individual.”
The mission statement, vision, and core values were clearly explained and discussed with
all new hires. Most desks and bulletin boards around the headquarters had these statements
displayed. The Executive Director and Director of Business believed the mission had formed the
culture of the organization and they effectively retained the employees that had adopted the
mission to guide daily work.
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The hospice’s mission statement, vision, and core values had key themes that form the
backbone of the organization. During discussions with each member of the team the words
“excellence,” “highest quality,” and “compassion” were regularly heard. The organization
believed in the importance of an interdisciplinary team approach to provide holistic care to show
compassion, and to treat and relieve suffering. The program hoped to reflect a spirit of caring
that emphasized comfort and dignity for patients and families. The organization believed in the
sacredness of life and respecting people of all cultures, lifestyles, values, and wishes.
The midwest palliative care team’s Registered Nurse and Social Worker believed that the
palliative care program and hospice shared mission statements, core values, and vision.
However, the Director of Business said there was a different vision for the palliative care
program. The lack of awareness of the palliative care program’s mission and vision by the
program’s staff was a weakness of the organization. The uninformed team members suggested
that the team had little to no contribution to the development of the vision and mission of the
palliative care program.
Leadership
Leaders provide direction and serve as role models for employees (Burke & Litwin,
1992). This factor deals with leadership processes, leadership styles, and employee perceptions
of the leadership. The midwest hospice and palliative care program as a whole believed that the
team provided the highest quality, cost effective, and equitable care in the region. By delivering
the best care, the organization hoped to become the most successful preeminent hospice and
palliative care team in the region. The specific strategy to achieve this goal was developed by
the Executive Director with the Director of Business. Prior to implementation the strategies
were discussed with the Board of Directors. The strategies were highly protected and were not
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discussed with the board or employees until time of implementation. The highly guarded
behavior and lack of transparency from upper management was frustrating to staff. This process
was non-negotiable and employees were given the opportunity to transition to new organizations
if they could not accept the method of strategy development.
Prior to the tenure of the current Executive Director, the midwest hospice and palliative
care organization was not financially sustainable. The organization needed dramatic change for
survival. The current Executive Director had a reputation of success in these types of
circumstances. It is reported that the Executive Director initially used a coercive leadership
style. He demanded immediate compliance and made many large changes within the
organization. After the organization recovered from crisis the leadership style transitioned to
authoritative in nature. The Executive Director mobilized the team towards a common goal and
mission. The Executive Director invited new hires to join in the journey if the applicant fits well
within the organization. The expectations, mission, and leadership style was clearly defined for
all new employees.
Organizational Culture
Organizational “culture is the collection of overt and covert rules, values, and principles
that are enduring and guide organizational behavior” (Burke & Litwin, 1992, p. 532). An
organization’s culture is an unspoken “meaning system” that is developed over time through an
organization’s history. The midwest hospice and palliative care program’s history was rooted
firmly in faith. The founders of the organization were affiliated with the Christian Reformed
Church and felt a strong calling to treat and minister to the dying members of the community.
Although the organization was not strictly faith based it claimed to be non-denominational and
was committed to addressing the spiritual care needs of all patients and families. A Christian
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faith was not a prerequisite to be employed at the hospice and palliative care organization but
many healthcare professionals had a strong faith that guided their care and work. In the same
way the organization ministered to all backgrounds and faiths while providing spiritual care
desired by the patient and family.
According to the Nursing Educator and the Director of Business, the arrival of the
Executive Director 5 years prior to this project triggered a large culture change. The Executive
Director set clear expectations and created a list of rules for all employees to follow. There were
3 main themes throughout the employee manual that were required from all employees. First,
“arrive to work on time, if not early, giving [the organization] 100% effort when you are
working; second, stay focused, do not spend time on issues you have no control over; and third,
get along with your coworkers.” Other topics included in the document were professionalism,
effective communication, honesty, respect, and leading by example.
Structure
Structure is how people are arranged into specific areas and outlines responsibility,
authority, communication, and relationships (Burke & Litwin, 1992). Structure articulates
hierarchy and who communicates and answers to whom. The midwest palliative care program
and the hospice program shared staff. The Registered Nurse and Social Worker were the only
employees that were solely designated for palliative care program. The providers, Clinical
Support Nurse, Patient Care Coordinators, Clinical Liaison, Community Liaison, Director of
Business, Director of Quality and Education, Director of Counseling, Director of Finance,
Billing Administrators, Director of Human Resources, and Executive Director were all shared
between hospice and palliative care programs. This made an organizational diagram very
complex. Nonetheless, the overall patient care team was very small and tightknit. The lines of
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communication, authority, and personal responsibilities were clear to those within the
organization.
Systems
Systems in the Burke-Litwin model represent the standardized policies and procedures
that facilitate workflow and evaluation of outcomes (Burke & Litwin, 1992). This concept
addresses factors from reward systems and evaluation of outcomes to goal and budget
development.
The midwest palliative care team was the only community-based palliative care
organization in the region with a physician-based model. This system revolved around the team
of physicians that guided treatments and conducted consultations. Although this system and the
roles of the supportive cast were clear the workflow, procedures, and policies regarding patient
follow-up were ambiguous. There was no system, standard, or procedure that guided patient
follow up. Furthermore, there was no consistent formal evaluation of outcomes. For 2 years the
program used the Edmonton Symptom Assessment Scale (ESAS) to measure symptoms and
monitor outcomes. The team did not believe the tool improved assessment or enhanced patient
care and desired to adopt a new tool. During the summer of 2016 the team decided to use the
Palliative Outcome Scale to measure quality data to evaluate the program’s effectiveness.
However, many providers found the tool cumbersome, the information derived irrelevant, and
did not appreciate how the tool interrupted the natural workflow of the consultation. As a result
many providers did not use the tool and outcomes were poorly evaluated by a standard measure.
Although the midwest palliative care team was consulted most for symptom management, the
organization had not consistently utilized a standard measure of symptoms. The lack of cohesion
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and consistency made it difficult to determine effectiveness of the providers and of the program
as a whole.
Management Practices
Management practices are how managers utilize resources to carry out the organization’s
mission and strategy (Burke & Litwin, 1992). This factor discusses behavior of managers and
how they encourage employees to be creative and complete tasks and projects.
Each quarter the managers and directors met to determine and evaluate goals for each
team. The goals had to surround 1 of 9 topic areas that contributed to meeting or exceeding the
budgeted census. The 9 topics that guided the creation of goals included; business principles
expertise, exceptional quality care, high customer satisfaction, long-term relationship building,
targeting our audience, create synergy, educate for expertise, hire the best, and benchmarking. It
was believed that goals guided by these 9 topics would contribute to the organization’s mission
of becoming the most successful and preeminent hospice in the state.
Each director managed the budget and determined department needs. Human resources
were managed within close relationships. Each individual operated very autonomously but had
support whenever needed. The roles and expectations of each staff member were clearly
articulated and understood. Quick face-to-face meetings were encouraged and members of the
team fed off each other’s performance. The patient care managers were largely focused on
determining patient needs and appropriate staffing oversight. These managers functioned more
day-to-day while directors oversaw larger, more strategic issues. The managers matched supply
and demand based on census. The unsteady and ever-changing utilization of nursing staff had a
large impact on the work-unit climate.
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Climate
The climate is the combination of impressions, expectations, and feelings of the staff and
teams that impact relationships with peers, bosses, and other teams (Burke & Litwin, 1992). The
work-unit climate was not always stable at the midwest palliative care and hospice program.
Staff contentment seemed to rely heavily on patient census. The staff preferred to stay busy and
active. However, during long periods of high census the climate could be tense and the staff had
a tendency to feel overworked. A steady and manageable workload contributed to the highest
employee morale. Within the palliative care team communication and workload were the 2 most
significant factors impacting the work climate.
The leadership team was very open to change and appeared capable of effectively
managing transitions. According to the Nursing Educator and Quality Director this was not true
prior to the tenure of the current Executive Director. Change was reportedly once met with
emotion and resistance. A number of employees who could not tolerate change decided to seek
new employment opportunities. After a large leadership turnover the remaining team was
excited about the trajectory of the organization. The team was capable of modifying practice and
had become experts at adapting to the current situation or climate. The team’s openness to
change and the ability to be led created a positive working environment where creating the best
patient experience was the focus.
Task and Individual Skills
Task requirements and individual skills are the knowledge, skills, and abilities required to
complete a task and meet a job requirement (Burke & Litwin, 1992). This is often articulated as
having an effective job to person match. According to the organization’s goals and objectives,
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“having the right people, in the right positions, doing the right things, at the right time, places the
organization in the right direction.”
The interview process for new hires was long and consisted of 3 different reviews. An
objective of the long process was that expectations were clear and the role understood. Another
main objective of the arduous interview process was that there be a solid job-person match. The
first interview was with the Human Resource Director. The next interview was with the manager
and at least 1 member of the team. The final interview was with the Executive Director. The
midwest hospice and palliative care organization preferred to recruit rather than post jobs online.
Management team members were always looking for hard to fill positions and accepted
applications even when positions were not open. This process focused on the long-term vitality
of the organization and was proactive rather than reactive ensuring the right person for the right
job.
Individual Needs and Values
Individual needs and values refer to the psychological factors that enhance an employee’s
job satisfaction (Burke & Litwin, 1992). This factor studies how employees derive worth from
tasks and work. Each individual has a set of values and beliefs. When tasks are consistent and
validate an employee’s beliefs, work can be enriching to life.
All employees interviewed during the organizational assessment discussed the
importance of alleviating suffering, providing quality care, and showing compassion. The
Registered Nurse stated that she felt most fulfilled when developing relationships with patients
and alleviating fear. The Marketing Director stated she felt most alive when overcoming
obstacles and moving the organization forward. The Marketing Director also enjoyed
communicating effectively to make complicated things easier. The Medical Director had a
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mildly different perspective. The Medical Director felt most valued and appreciated when he
was able to make a meaningful difference in a patient’s life. A large reason the Medical Director
transitioned from emergency medicine into palliative care was to have a gentler patient to doctor
relationship. Whether through difficult discussions or optimal symptom management the
Medical Director received fulfillment by leaving a meaningful impression in people’s lives.
From Marketing Director to Medical Director and Registered Nurse the needs and values were
consistent. The employees of the hospice and palliative care program were most fulfilled
through making a meaningful difference in people’s lives.
Motivation
Motivation is the desire, incentive, or inspiration to complete a task (Burke & Litwin,
1992). Motivation is also described as the energy and power to achieve a goal in order to attain
satisfaction. This intangible factor is often generated through values and beliefs. Therefore,
there is significant overlap between employee’s values and motivation.
Through interviews it was clear the members of the palliative care team were motivated
to provide the highest quality care. However, each individual had more specific factors that
served as motivation. For example, the Registered Nurse obtained the most satisfaction through
impacting a patient’s day-to-day life but was specifically motivated by completing individual
tasks and completing a daily checklist. The Director of Quality and Education was motivated by
working independently and utilizing a variety of skills to fulfill a large range of responsibilities.
The directors were highly motivated by competition. The directors deeply desired to be the best
hospice and palliative care team in the region and the competition inspired them to action and
stimulates new initiatives and strategies.
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Individual and Organizational Performance
The final factor of the Burke-Litwin organizational model of performance is a
transactional factor (Burke & Litwin, 1992). Individual and organizational performance is the
culmination of all other factors and examines the results produced by the organization.
The palliative care team used a variety of metrics to determine outcomes. Possible
palliative care metrics were patient census, number of completed advanced directives,
effectiveness of symptom management, patient satisfaction, number of patient hospital visits, and
number of patients who transition to the organization’s hospice program.
The organization was measuring patient satisfaction through an online survey sent out to
all patients. Census, percentage of patients with advanced directives, and number of patients
transitioning into hospice were monitored regularly. The organization was not however,
monitoring other quality indicators. Measuring the organization’s ability to manage symptoms
was an area of opportunity as symptom management is the most common reason for a
consultation with the midwest palliative care team. Unrelieved symptoms significantly impact a
patient’s quality of life and ability to function (Cleeland et al., 2000). Unpleasant symptoms
profoundly alter and limit activities, negatively impact family relationships, impair work
productivity, and decrease quality of life (Dodd et al., 2001). A good symptom inventory is
important and should improve symptom detection and treatment. Thorough symptom
assessment leads to more informed clinical decision making and more effective medication
regimens. Due to reimbursement procedures nurses and providers are not reimbursed for follow
up patient interactions. Within the reimbursement structure it becomes even more important to
establish effective medication regimens that provide optimal symptom relief, which require less
provider and nurse follow up. Reducing follow up interactions saves providers time and
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decreases cost. Additionally, providing quality care generates positive word of mouth marketing,
which should increase patient census. Providing quality care also increases retention of
palliative care patients that transition to hospice care.
SWOT Analysis of Organization
The midwest hospice and palliative care team was studied analyzing strengths,
weaknesses, opportunities, and threats (SWOT). A SWOT analysis provides a quick and
succinct model to identify areas of high performance and opportunities for improvement. A
SWOT analysis can help an organization capitalize on strengths and improve weaknesses.
Strengths
The midwest palliative care team had a unique physician-based model. The model
ensured that patients saw a physician at the time of consultation and frequently during the first
follow up. A physician-based model places a larger workload on the physicians and can be more
expensive, but the organization believed this leads to the highest quality of care. There was also
a culture of “going above and beyond” for patients. This became the palliative care team’s
reputation in the community and the staff fed off of this culture. The palliative care team’s
relationship with the hospice program expanded the services the palliative care program could
provide. After hours the on-call hospice nurse provided 24-hour support to meet palliative care
patient’s needs. The palliative care team had a fulltime social worker and if needed could access
the hospice’s bereavement and pastoral care services as well. The team had a reputation of
seeing patients quickly. In fact, it was common for patients to be seen the same day the referral
was written.
The palliative care team covered a large area providing care in home and in facilities
spanning 5 counties. The small team size was another strength of the midwest palliative care
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program. Patients with complex diseases and multiple comorbidities were exposed to many
healthcare professionals and a multitude of specialists. A small team streamlines communication
and reduces the number of patient handoffs. Due to the small size of the team, the patients
consistently talked to the same professionals who had developed a relationship and knew the
patient’s story.
Weaknesses
The midwest palliative care team’s 2 largest weaknesses were poor focus on advanced
directives and inconsistency in gathering quality data. During the spring of 2016, only a third of
the palliative care patients completed an advanced directive. This statistic improved but more
work needed to be done to asess and assure patient’s wishes. The organization’s difficulty
gathering quality data had been discussed and was the focus of this quality improvement
implementation project. An additional weakness identified by multiple members of the palliative
care team was the underutilization of the social worker. Patients were not adequately screened to
receive social work services. The social worker had the most available time compared to other
members of the palliative care team.
The connection with the organization’s hospice program was confusing to many
prospective patients and families. The midwest hospice and palliative care team was not
affiliated with a hospital or major healthcare system. Many prospective patients perceived this
as a weakness as well. Patients with a terminal illness often utilize hospital services. Each time
a patient is hospitalized and discharged communication must occur between the hospital system
and the palliative care team. This transition of care creates opportunities for fragmented care and
miscommunication. Medication reconciliation and updates in the patient’s history must occur
each time another entity initiates care. Variations in electronic health records make information
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sharing even more challenging. Patients are often aware when care is poorly coordinated and
poorly coordinated care increases the stress a patient experiences.
Opportunities
The most significant opportunity articulated by the palliative care team was supported in
the literature. A knowledge gap existed among community members and even primary care
providers (M. A. Bakitas et al., 2015). The organization was committed to allocating resources
to provide education to the community and healthcare providers about the services palliative care
could deliver. The organization believed there was strength in a physician-based model and
boasted of quick consultations following referrals. However, there was poor community
awareness about these strengths. This was a significant opportunity for the organization to move
forward.
Threats
Hospice and palliative care services were available through many organizations for
persons seeking these services. At the time of this project, a number of large hospital systems in
the region were in the process of developing a community based palliative care program. In an
already saturated market, referrals for the midwest hospice and palliative care team could
diminish. Another hospice organization in the region offered unique services and was another
competing organization. This other hospice program had a hospice facility for patients who were
unable to die at home. And at this facility the other hospice organization had highly sought after
designated Medicaid beds. The Medicaid beds were in high demand and many patients signed
on with the other hospice organization in the hope of securing one of these coveted beds. In
short, competition was the largest threat to the midwest hospice and palliative care organization.
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SWOT of Proposed Intervention
Strengths
The midwest palliative care team identified the need for quality data regarding symptom
experience. The organization was highly motivated to implement a symptom inventory tool to
improve symptom assessment, improve clinical decision-making, determine effectiveness of
treatment regimens, and gather data on provider effectiveness. The organization had a mission
and strategy that strived for excellence, competitive leadership that wanted to be the best, a
culture that accepted change, a system that needed quality data, and professionals that desired to
improve performance.
Weaknesses
The organization had previously failed to implement and sustain previous attempts to
assess patient symptom experience through surveys and questionnaires. These prior surveys
failed because the tools were perceived as too time intensive, the information derived too
irrelevant to the providers during consultation, and the tool interrupted the natural workflow of
consultations. Another potential weakness was the lack of policy and procedures outlining
timeframes for patient follow-up. The implementation strategy of this project created a new
workflow and process requiring more frequent and structured patient follow-up.
Opportunities
Generating quality data is important to present to third party payers, the CMS, and
invested community stakeholders. The midwest hospice and palliative care program received
many sizeable monetary donations from persons who reside in the geographical area. According
to the hospice leadership, their charitable donors desire to see impact from the donations
provided. Generating and tracking quality data can also provide inter-provider accountability
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and track the effectiveness of the prescribers. Overall, gathering quality data increases
accountability to patients, government, charitable donors, the community, and workers within the
organization.
Threats
The organization’s prior failures to implement a symptom experience assessment tool,
perceived lack of time during consultations, and the undefined follow up procedures were all
possible threats to implementation. Additionally, there was no clear accountability or incentive
to incorporate this procedure into practice. Implementation strategies were threatened until the
palliative care team was able to observe a tool that has direct impact on patient care.
Key Stakeholders
The key stakeholders of the midwest hospice and palliative care team consisted of the 90
professionals, 200 volunteers, the Board of Directors, the charitable donors, the community, and
the patients the organization serves. The organization had a large community support base
consisting of volunteers and donors. According to the Executive Director, without the generosity
of community donors the organization would not be sustainable. The palliative care program
rendered services that cost substantially more than the organization received annually. In fact,
the excess funds generated from the hospice program supplied for the financial losses of the
palliative care program. The organization did not make the decision to provide palliative care
services because it was fiscally advantageous, rather palliative care was provided because the
organization believed that palliative care services were needed in the community to improve the
quality of life for patients impacted by life limiting illnesses.
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Project Plan
Purpose of Project
The midwest hospice and palliative care organization had prioritized the measurement of
symptom experience but had been inconsistent in utilizing a tool during consultation and follow
up. Therefore, the purpose of this project was to implement and evaluate an evidence-based
symptom inventory tool with 4 additional short answer questions in a community based
palliative care program. The symptom assessment tool provided a quality measure for the
organization to assess outcomes. The short answer questions were used to identify trends and
themes of perceived barriers to palliative care services by rural and non-rural patients. Finally,
the organization’s acceptance of the implementation was evaluated through staff questionnaires.
The proposed project had 2 objectives: 1) meet the organization’s needs of generating
quality data, and 2) improve understanding of rural populations and the challenges the population
experiences in accessing palliative care services. The organizational objectives of this project
were: 1) identify a symptom inventory tool that met the needs of the organization, 2) create an
evidence-based project design with follow up recommendations, 3) guide implementation, 4)
evaluate the protocol’s effectiveness, and 5) provide recommendations to sustain the project.
The objectives focused on rural populations included: 1) determine the duration of time a patient
suffered from unpleasant symptoms prior to obtaining access to services, 2) identify patient
perceived barriers to receiving palliative care, 3) determine what mode of communication was
effective in educating the patient on palliative care, and 4) determine the patient’s perceptions of
geography and access to services.
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Type of Project
This project was a quality improvement initiative. The project’s primary objective was to
implement a symptom inventory tool to provide quality data to track the palliative care
program’s effectiveness in managing patient symptoms. Another primary objective of the
project was to gather insights regarding the impact of demographics on patient perceived barriers
to accessing palliative care services. Therefore, an additional questionnaire was administered at
consultation to identify themes for both rural and non-rural patients in palliative care barriers and
utilization. A secondary objective of the proposed project was quality improvement through
improved assessment. Frequent standardized assessment of patient symptoms has the potential
to enhance provider effectiveness and improve patient care (Ripamonti et al., 2012).
Setting and Needed Resources
The midwest hospice and palliative care program was a non-profit, Medicare-certified,
Joint Commission accredited hospice organization. The palliative care program was a member
of the Center to Advance Palliative Care (CAPC). The hospice and palliative care team was
located in the midwest but provided care in the home, clinic, and in many facilities across the
region. The organization’s service area spanned 5 surrounding counties.
The implementation of this quality improvement initiative required 900 dollars to
purchase the MDASI in English and Spanish; this cost was absorbed by the organization.
Additional needs for the proposed project included a phone to make phone calls, a computer, and
secure email access to communicate about new consults and discuss follow up information.
Budget
The MDASI core inventory in English cost 100 dollars per healthcare provider. The
midwest palliative care team requested a Spanish form of the symptom inventory as well, which
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cost an additional 100 dollars per provider. The organization had 4 providers. With the addition
of an administration fee the overall cost of implementation was 900 dollars. The MDASI was
purchased by the organization in anticipation of long-term use.
Project Design
After thorough consideration of a handful of tools and an evaluation of the needs of the
organization, the palliative care team chose the MDASI to measure symptoms and evaluate the
palliative care team’s performance. The doctoral student conducted phone calls to patients to
administer the MDASI and the perceived barriers questionnaire. The perceived barriers
questionnaire was administer following the administration of the MDASI during the first
interaction only. The MDASI was administered: 1) within 48 hours of consultation to determine
symptom burden, 2) 3-7 days after consultation, 3) every medication regimen change, 4) 3-7
days after a medication regimen change, and 5) 1 month following consultation. Rationale for
patient follow-up was discussed in the “Measuring Symptoms” section. Start and stop times of
MDASI administration was documented to determine administration time. Frequency of
MDASI administration was also monitored. Following each phone call the completed MDASI
was sent via email to the palliative care team’s Registered Nurse for review and to upload the
MDASI into the electronic health record. Any additional information regarding the patient was
communicated to the team through the organization’s encrypted email, over the phone, or faceto-face. A staff questionnaire was administered midway through the implementation project to
all healthcare professionals within the palliative care program to evaluate objectives
The midwest hospice and palliative care team spanned 5 counties. According to the
United States Census Bureau 2 of the 5 counties are considered rural (US Census Bureau, 2015).
The remaining 3 counties the program served are considered non-rural. Patients that completed
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the perceived barriers questionnaire were separated into rural and non-rural subgroups by county
of residence.
Ethics and Human Subjects Protection
The Grand Valley State University Human Research Review Committee determined that
this project was not human research. The project was a quality improvement initiative designed
to improve symptom assessment, provide symptom management quality data, and increase
understanding of patient perceived barriers to palliative care services. Similar to all quality
improvement initiatives, patient data was collected and subject to confidentiality regulations.
Data was maintained safely within the organization’s offices. A door requiring keycard access, a
locked office, and a password-protected computer protect patient data. The doctoral student
obtained the patient’s name and county of residence upon consultation. All patient identifiers
were removed and sensitive information was translated into code. The patient-identifying key
was stored on the organization’s computers and was not removed from the site at any time.
Information was shared between the palliative care staff using the organization’s secure email
account, over the phone, or face-to-face. During statistical analysis an encrypted thumb drive
was used to transport data to the University’s statistics department. After the scholarly project
was uploaded into Scholar Works all information was given to the organization via encrypted
email and information was deleted and destroyed.
Participants and Sampling
Participants included all English-speaking patients living at home or in assisted living
facilities referred to palliative care services for symptom management. Additional inclusion
criteria included the ability to self-report symptoms. Implementation began February 15, 2017
and ended April 7th upon completion of 25 qualitative questionnaires. Consults from skilled
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nursing facilities or hospitals were not included in the sample. Patients in hospitals were
excluded from participation because the scholarly project focused on the community-based
patient population. Patients residing in skilled nursing facilities were excluded due to feasibility
concerns. Based on the experience of the palliative care practitioners, they felt that many
patients residing in skilled nursing facilities are unable to self-repot symptoms due to cognitive
abilities. Additionally, many of the skilled nursing facility patients do not have access to a
phone. Therefore, administering the MDASI with patients would require time from the skilled
nursing facility staff adding to the staff’s workload. To fulfill the objectives of the project in
implementing and evaluating a symptom experience tool, the palliative care practitioners wanted
to avoid data that could confound the implementation. Persons in skilled nursing facilities will
be considered at a later date.
Measurement
The MDASI was the primary measurement tool utilized in the proposed project. The
answers to patient perceived barrier questions were synthesized to draw themes. Symptom
scores were gathered and changes in scores monitored over time. The frequency of tool
administration was counted, the amount of time used to administer the MDASI was calculated,
and the project’s acceptability by staff was measured via the “MD Anderson Symptom Inventory
Implementation Questionnaire.”
Steps of Implementation
The project commenced on February 15, 2017. All new referrals were called and surveys
were administered. Patients were enrolled in the project on a rolling basis. On March 15, 2017
the “MD Anderson Symptom Inventory Implementation Questionnaire” was administered to
determine the staff’s opinions regarding the implementation and to guide a plan for
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sustainability. The scholarly project ended data collection on April 7, 2017 upon completion of
the 25th patient perceived barrier questionnaire.
Project Evaluation Plan
The project was evaluated in a number of ways. Frequency of tool utilization per patient
and time to complete the MDASI were calculated. A staff questionnaire was administered on
March 15, 2017 to all healthcare professionals within the palliative care program to evaluate
objectives, determine workforce opinion, and to guide the sustainability plan. Questions in the
staff questionnaire were posed in Likert format and are available in Appendix I. The questions
asked the palliative care team: 1) whether the MDASI provided timely and helpful information;
2) contributed to assessment of symptoms; 3) effectively evaluated medication regimen
effectiveness; 4) whether follow up intervals were practical and effective; and 5) whether the
MDASI and protocol should be sustained in the organization.
Project Outcomes
Overall, 29 referrals were sent to the midwest palliative care program between March 15,
2017 to April 7, 2017. Of the 29 referrals, the MDASI was administered and completed by 19
patients and the qualitative analysis of patient perceived barriers was completed by 25 patients.
Of the 19 patients surveyed with the MDASI, only 10 were consulted early enough in the quality
improvement initiative to be followed for a month. However, among these 10 patients only 6
completed an MDASI at 1-month post consultation. Of the 19 patients referred for palliative
care services 15 were referred for pain, 3 for shortness of breath, and 1 for fatigue.
Of the 29 patients referred for palliative care services, 5 were rural and 24 were nonrural. Approximately 72% of the perceived barrier questionnaire responders resided in Ottawa
County. A pie chart of the counties represented in the qualitative analysis is available in
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Appendix J. Of the 25 patients surveyed with the perceived barriers questionnaire 4 lived in an
assisted living facility, during implementation 2 patients transitioned from palliative care into
hospice care, and 2 patients deceased during the scholarly project. The qualitative questionnaire
provided information regarding patient perceived barriers to palliative care services and the
implementation of the MDASI provided population characteristics of patients referred for
palliative care services.
MD Anderson Symptom Inventory Administration
Of the 19 patients that completed the MDASI, 15 patients sought consultation for pain
management. The patients consulted for pain were in significant distress with an average pain
rating of 7.93 out of 10 at time of consultation. However, the palliative care team was able to
provide patients with considerable relief. Patients who were consulted for pain and had a follow
up interaction in 1 week reported a mean 6-point improvement of pain. Appendix K presents a
boxplot of patient reported pain at consultation, Appendix L presents a table of patient reported
pain at consultation, and Appendix M presents a table of pain improvement measured with the
MDASI.
The symptom cluster of pain, fatigue, and distress are frequently studied in literature.
These symptoms as well as the interference of enjoyment of life inventory item were studied
closer to learn patient characteristics and determine program effectiveness. Of the 19 patients
that completed at least one MDASI the mean fatigue score at consultation was 6.74 out of 10 and
the average distress score was 5.47 out of 10. On a scale of 0 to 10 patients were asked how
much symptoms interfered with enjoyment of life. A score of 0 implied symptoms did not
interfere at all and a score of 10 implied symptoms interfered with enjoyment of life completely.
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The average response to the inventory item was 6.84 at consultation. Appendix N presents these
symptom scores at consultation.
A key objective of the project was to provide a symptom inventory that gathered quality
measures to monitor the program effectiveness in managing symptoms. During implementation
6 patients were followed for a month. Symptom improvement was studied in these patients at 1
week compared to baseline and 1 month compared to baseline. At 1 week the patients
experienced: a mean improvement of pain by a score of 2.67; improvement of fatigue by a score
of 1.17; improvement of disturbed sleep by a score of 0.83; and a decrease of symptom
interference on enjoyment of life by a score of 0.67. At 1 month the symptom reductions
observed were sustained and reduced further. In fact, at 1-month pain scores were improved on
average by 3.5 compared to baseline; fatigue scores improved on average by 1.67; disturbed
sleep scores improved by 3; and interference of enjoyment of life scores improved on average by
2 points. Appendix O presents a table of improvement of MDASI scores at 1-week compared to
consultation and Appendix P presents a table of improvement of MDASI scores at 1-month
compared to consultation.
The number of patients observed is far too small to imply significant results or draw
generalizable information. The objective of the scholarly project was to create a means to
generate and gather quality data. The organization needed a method to monitor program
effectiveness in order to have reportable data. The results obtained during the quality
improvement initiative provided evidence that the MDASI met the organization’s objectives of
generating quality data and tracking performance.
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Patient Perceived Barriers to Palliative Care Services
Immediately following the administration of the MDASI, 4 short answer questions were
posed to patients during the consultation phone call. A thematic analysis was conducted on the
qualitative questionnaire to examine and record patterns observed in responses. The doctoral
student transcribed responses during the phone call. During analysis responses were coded to
determine frequencies and co-occurrences. Finally, themes were induced and patterns are
discussed below.
How long have your symptoms affected your life? When reporting duration of time
symptoms affected a patient’s life, 5 patients reported duration in years and 20 reported duration
in months (symptoms affected life less than 1 year). Of the 20 patients reporting duration in
months, 3 patients reported that symptoms have affected life for years but clarified that
symptoms have worsened within a time described in months. Additionally, 3 more patients that
reported duration of symptoms in months clarified by saying, “pain got worse,” “pain was up and
down until,” or “pain got out of control” prior to providing a duration of time in months. The 20
patients that described duration of symptoms in months reported an average duration of
symptoms lasting 4.45 months prior to receiving a referral for palliative care. The 5 patients that
described duration of symptoms in years reported an average duration of symptoms lasting 3.9
years prior to obtaining palliative care services. Interestingly, the 3 patients that suffered the
shortest duration of time prior to obtaining a palliative care consult experienced an acute event
that led to quick onset of symptoms and a quick referral.
What has kept you from receiving palliative care before now? A number of barriers
were perceived and reported by patients. The most frequently reported barrier to palliative care
was lack of knowledge of the existence and role of palliative care. In all, 17 patients did not
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receive palliative care sooner because of this knowledge gap. Of these 17 patients, 15 responded
identically by saying, “I didn’t know about it.” The remaining 2 patients said, “I never thought
about it” and “I didn’t know where to start.” This is the strongest theme induced by the thematic
analysis. The remaining themes were only shared by 1 or 2 responders. Of these, 2 patients did
not seek palliative care sooner because patient and family wanted to manage symptoms through
additional healthcare support such as home care or assisted living. Lastly, 2 responders reported
there were no barriers. Both patients had a very short duration of symptoms and attained a
referral and consult quickly.
All other barriers were only reported by a single patient. A patient admitted to under
reporting symptoms to the primary care provider (PCP) and said, “I didn’t tell him how bad I
was. There were a lot of things I didn’t tell him.” The patient stated that she had felt poorly for
a long time. She finally received palliative care after honestly talking to her PCP about her
symptom burden. The issue of under reporting symptoms was identified during the literature
review and validates the need for a quality symptom assessment tool (Kerr, Tangeman, et al.,
2014). A patient residing in a rural community received a palliative care referral from the
treating oncologist. The patient stated that, “there was nothing the doctors could do for me.”
This patient did not receive palliative care earlier because the oncologist wanted to be
responsible for controlling the patient’s treatments and symptoms. This patient reported duration
of pain affecting life in years and had a substantial symptom burden. Palliative care was not
utilized sooner for 1 patient because family was not prepared to accept palliative care services.
The patient’s wife admitted she was not ready for palliative care - as if accepting palliative care
services was admitting defeat. When asked, 1 patient responded that palliative care services
were not attained earlier because the patient lacked a PCP. As soon as the patient was able to
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access a PCP a palliative referral was obtained. Lastly, a rural patient’s PCP wrote a palliative
care referral for the patient without notifying the patient and wife of the referral and without
having a discussion about palliative care. The wife was upset about the consult and became
defensive about the care she provides the patient. The wife argued that she provides adequate
care for the patient and did not need help. After a long discussion about palliative care’s role the
wife believed palliative care was not needed or desired.
How did you learn about palliative care? Patients learned about palliative care most
frequently from a PCP. Specifically, 9 of the 25 patients learned about palliative care from the
patient’s primary care provider. An analysis of co-occurrences deduced that 4 of the 5 patients
that reported symptom duration in years learned about palliative care from a PCP. Although
positive that patient’s PCPs are educating patients regarding palliative care this co-occurrence
would suggest that perhaps PCPs are waiting too long to consult palliative care services.
Oncologists were the second most frequent source of palliative care knowledge, educating 4
patients. Education also came from home health nurses (3 patients); friends and family members
(2 patients); in-patient non-palliative care healthcare staff (2 patients); other specialists (2
patients); in-patient palliative care team (1 patient); and on the phone with doctoral student (1
patient). A patient knew about palliative care already because she was once a hospice nurse.
Patients were educated about palliative care from a multitude of different sources. No strong
relationships were identified between barriers to palliative care and source of education about
palliative care services.
Do you believe where you live impacted your ability to receive palliative care? All
25 patients responded “no” to this question. In addition to reporting “no,” 2 patients believed
living in an assisted living facility improved access to palliative care services and 1 patient
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believed living in Ottawa County improved the patient’s capability to know about and access
palliative care services. Weaknesses of this question are discussed in the “Implications for
Practice” section.
Characteristics of rural populations. Rural patients were highly hesitant to discuss
health related information over the phone. Of the 5 rural patients referred for palliative care
services, all were skeptical of the doctoral student’s motives and only 1 patient was willing to
participate in the MDASI. As discuss earlier, a rural patient declined palliative care after being
referred to palliative care without a discussion with the PCP. This patient and wife were
extremely skeptical of palliative care and perceived the referral as an insult to the spouse’s
ability to care for the patient. A couple patients refused to provide any information to the
doctoral student. A patient refused to provide any information because “[He] never [discusses]
personal information over the phone.” The patient asked the doctoral student, “How can I know
that you are who you say you are?” The next day the provider drove to the patient’s home to
conduct the consultation and the patient refused to let the doctor inside. The patient asked the
physician to return another day. During a phone call the patient answered the phone and
abruptly said, “You’ll need to talk with my wife. She handles all of my medications.” Before
being able to respond the phone was handed to the patient’s wife. After describing the
importance and relevance of the symptom inventory the wife and husband refused to participate
because, “it’s been a long day and [the patient] isn’t feeling up to it. We would rather share this
information one time and directly to the doctor tomorrow.” The wife argued that it did not make
sense to tell multiple people the same story. During another phone call attempt to reach a rural
patient, the mother answered the phone. The mother did not want the patient to be burdened by
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the questionnaires and believed the information was too intimate to share over the phone without
an established relationship with the staff or program.
Although, only 3 rural patients responded to the qualitative questionnaire of patient
perceived barriers, 2 of them learned about palliative care during an inpatient admission. Also
noteworthy, similar to information found during the literature review at least 4 patients had
strong family support (Hughes et al., 2004). Early into each phone call with rural patients and
family members it was clear that 4 patients received care from an informal caregiver. An
individual had a very supportive mother and 3 patients had a highly invested spouse. The
answers from the questionnaire were not thematically remarkable or different between rural and
non-rural patients. The overall interactions however varied greatly between rural and non-rural
populations. During implementation patients were not able to participate with the MDASI or the
patient perceived barriers questionnaire for a number of reasons. However, only patients
residing in rural communities refused to participate. The patients residing in rural areas were
more skeptical of healthcare, hesitant to share information, and more likely to have an invested
family member as the primary caregiver.
Evaluation of MDASI Acceptability
The scholarly project was evaluated in a number of ways. Frequency of tool
administration per patient and time to complete the MDASI were calculated. A staff
questionnaire was distributed to evaluate project objectives and to determine palliative care staff
opinion regarding the scholarly project. The 10 patients consulted early enough in the quality
improvement initiative to be followed for a month were observed for frequency of tool
administration. The MDASI was administered to the 10 eligible patients an average of 2.9 times.
The administration of the MDASI took an average of 6 minutes and 27 seconds with a median of
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5 minutes and 55 seconds. The minimum administration time was 3 minutes and 1 second and
the maximum administration time was 11 minutes and 25 seconds. According to Cleeland et al.
(2000) administration of the MDASI requires an average of 5 minutes to complete.
Administration time was longer during the scholarly project. This difference in time to
administer the MDASI is likely due to patient tendencies to share additional information beyond
the questions of the symptom inventory. A frequency table of MDASI administration is
available in Appendix Q and a descriptive table of time to administer the MDASI is available in
Appendix R.
The number of patients observed is far too small to imply significant results or draw
generalizable information. The objective of the scholarly project was to create a means to
generate and gather quality data. The organization needed a method to monitor program
effectiveness in order to have reportable data. The results obtained during the quality
improvement initiative provided evidence that the MDASI met the organization’s objectives of
generating quality data and tracking performance.
The staff questionnaire was the final mode of project evaluation. All 5 palliative care
team members completed and returned the survey. Responders included 2 physicians, 2
registered nurses, and 1 social worker. The staff as a whole agreed strongest that “the MDASI
contributed to the assessment of patient symptoms” and “the MDASI was effective in evaluating
medication regimen effectiveness/patient condition.” The weakest agreement of the staff
questionnaire was that “the administration and follow up intervals of the MDASI were practical
and effective for patient care and monitoring.” One respondent disagreed with this question and
wrote on the survey, “frequency is an issue” believing the MDASI was administered too
frequently. Other than this one disagreement response all other respondents agreed or strongly
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agreed with each item on the implementation staff survey. The responses to the staff survey
guided the sustainability plan and will be discussed below. Appendix S contains a bar graph
depicting the means and standard deviations of responses to the staff questionnaire. In general,
this project met the needs of the organization,
Sustainability Plan
The palliative care team struggled to consistently utilize prior quality measurement tools
in place. Palliative care staff attributed the failed implementation attempts to the previously
implemented tools. The providers believed the correct tool would be worth utilizing. To combat
this barrier the palliative care team decided together to utilize and implement the MDASI. The
perception of the tools was one barrier but another complaint regarding prior implementations
was the disruption of the workflow during consultation. The palliative care providers were
frustrated with the time to administer the tools and felt transitions prior and following the tool
were cumbersome. To alleviate this barrier the providers themselves did not distribute the
questionnaire or gather data.
During the implementation process the doctoral student completed the MDASI over the
phone. Following the completion of the project the Registered Nurse continued to complete the
MDASI over the phone. During the organizational assessment, multiple time-consuming
responsibilities of the Registered Nurse were identified that could be completed by another
employee. Many of these tasks did not require a Registered Nurse’s knowledge or expertise.
The doctoral student communicated to the organization that reallocating tasks would better
utilize the Registered Nurse and was essential for the sustainability of this project. Intead of
reallocating tasks, the organization elected to hire an additional fulltime Registered Nurse to
improve the workload and ensure sustainability of the quality improvement project.
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During implementation the Registered Nurses voiced concern regarding the workload of
administering the MDASI prior to and following every medication regimen change. This
concern resulted in a change in frequency of MDASI administration. Therefore, the organization
agreed to administer the MDASI at consultation, 1 week following consultation, 1 month
following consultation, and each month thereafter. The MDASI would continue to be
administered and uploaded into the patient’s electronic health record and the quality data would
be maintained by the Director of Quality and Education. The Doctor of Nursing Practice (DNP)
project is the culmination of the DNP education experience and is a final opportunity to learn,
grow, and display the essentials in practice within a functioning organization. The DNP
essentials utilized within this scholarly project are discussed below.
Doctor of Nursing Practice Essentials
The DNP essentials were established to outline fundamental curricular competencies in
Doctor of Nursing Practice (DNP) programs (American Association of Colleges of Nursing,
2006). The achievement and growth of the 8 competencies are attained in a number of ways
throughout the DNP program.
Essential I: Scientific Underpinnings for Practice
Essential I is the scientific underpinning for practice competency. This essential
demonstrates an understanding of complexity of practice and the conceptual foundations of
nursing (American Association of Colleges of Nursing, 2006). This essential was demonstrated
in this project by the utilization of nursing theory as a conceptual framework for the phenomenon
of unpleasant symptoms and through the utilization of an implementation model. Essential I was
also fulfilled through the evaluation of symptom literature and, in response, the development of a
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new strategy to assess and monitor patient’s symptoms. Finally, this essential was demonstrated
through evaluation of the implemented strategies.
Essential II: Organization and Systems Leadership for Quality Improvement
Essential II is the organization and systems leadership for quality improvement and
systems thinking competency (American Association of Colleges of Nursing, 2006). Conducting
an organizational assessment using the Burke-Litwin Model enacted this essential. This project
also demonstrates essential II by providing a means of accountability for the organization’s
performance in managing symptoms. This quality improvement initiative provides quality data
that can be monitored by the organization, reported to government agencies, and used for
advertisement purposes. Throughout the implementation process the doctoral student enacted
essential II through advanced communication skills and through leadership of the quality
improvement initiative.
Essential III: Clinical Scholarship and Analytic Methods for Evidenced-Based Practice
Essential III is the clinical scholarship and analytical methods for evidence-based practice
competency (American Association of Colleges of Nursing, 2006). This essential was
demonstrated through critical appraisal of pertinent literature and by evaluating current practices
within the organization. The organization’s assessment techniques, processes, and follow up
procedures were analyzed to guide the quality improvement initiative. The quality improvement
initiative methodologies were also evaluated to promote effective, efficient, and equitable patient
care, further utilizing essential III. The doctoral student was a collaborative consultant for the
organization to improve symptom assessment and to provide quality data. Lastly, uploading the
scholarly project into Scholar Works will enact essential III through disseminations of findings.
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Essential VI: Interprofessional Collaboration
Essential VI is interprofessional collaboration for improving patient and population
health outcomes competency (American Association of Colleges of Nursing, 2006). This
essential was enacted by frequent communication with all members of the palliative care team.
In addition, the doctoral student led the palliative care team in discussions of symptom
management, available symptom inventory tools, and presented evidence of the importance of
routine symptom assessment with a standard tool.
Essential VII: Clinical Prevention and Population Health
Essential VII is clinical prevention and population health for improving our nation’s
health competency (American Association of Colleges of Nursing, 2006). This essential was
exhibited in a number of ways during the scholarly project. Palliative care’s ability to accurately
and thoroughly assess and treat symptoms improves the quality of life of this population (Hui et
al., 2014). The purpose of this quality improvement initiative was to improve symptom
assessment to further improve quality of life for the palliative care population. Determining
barriers to palliative care and examining themes between rural and non-rural patients is another
way this essential was enacted. Improved knowledge regarding barriers to palliative care can
guide strategies to reach populations with poor access to improve population health and quality
of life.
Essential VIII: Advanced Nursing Practice
Essential VIII is advanced practice nursing expertise competency (American Association
of Colleges of Nursing, 2006). This essential was enacted through personal engagement with
patients over the phone. During phone interactions the doctoral student assessed multiple
symptoms, quality of life, and distress. Communications regarding symptoms and disease
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progression required tact, discernment, and sensitivity. Over the phone the doctoral student
needed to be perceived as professional, compassionate, and trustworthy. After multiple
interactions, relationships were built with patients. Essential VIII was further enacted through
educating the Registered Nurses on information learned during the quality improvement
initiative. Lastly, this essential was enacted during the scholarly project by utilizing conceptual
and analytical skills to evaluate and understand links in practice, populations, and policies.
Implications for Practice
Palliative care services are provided in an assortment of settings including hospitals,
outpatient clinics, rehabilitation facilities, assisted living facilities, skilled nursing facilities, and
inside patient’s homes (Meyers, Kerr, & Cassel, 2014). Community-based palliative care is a
comprehensive and multidisciplinary service that follows patients across the disease trajectory
through transitions of care and a variety of healthcare settings (Kamal, Currow, Ritchie, Bull, &
Abernethy, 2013). Community-based palliative care teams have the advantage of seeing a
patient’s environment to further individualize care and extend care to meet the need of patients
with life limiting illnesses who are home bound. This home-based approach is an opportunity to
reach rural populations and improve the care these patients receive.
A significant component of palliative care and its success on patient outcomes is the
ability of the team to manage distressing symptoms (Hui et al., 2014). Unpleasant symptoms
impact almost every facet of a patient’s life and impairs functional capacity and increases
patient’s distress (Carlson et al., 2012; Cleeland et al., 2000). Patients struggling with a life
threatening illness have a right to good symptom management. In order to provide the best care,
symptoms must be measured regularly and accurately. A quality symptom inventory identifies
symptoms, measures severity, and is sensitive enough to detect responses from treatment
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(Cleeland et al., 2000). Although no symptom inventory is perfect, the MDASI best suited the
needs of the midwest community based palliative care team.
Successes
The quality improvement initiative established and implemented a sustainable plan to
obtain quality measures, improve symptom assessment, and standardize patient follow up
procedures. By implementing the MDASI the organization can learn about its patient’s
characteristics, track provider effectiveness, and report the program’s performance to community
stakeholders.
The qualitative analysis on patient perceived barriers to palliative care is consistent with
the concerns already noted in literature. Patients in both rural and non-rural communities are
suffering from unrelieved symptoms for long durations of time prior to receiving palliative care.
The qualitative analysis was also consistent with literature that suggests a knowledge gap in
communities. The overwhelming majority of patients did not receive palliative care before
referral because the patient or family “didn’t know about it.” Although this knowledge is not
new, it validates the need for improved widespread education of palliative care’s existence and
role. The qualitative analysis also noted a difference in trust between rural and non-rural
patients. Rural patients were less trusting, more skeptical, and more reluctant to discuss sensitive
matters such as health without an established relationship. According to the literature, rural
patients receive more informal support and caregiving than non-rural patients (Hughes et al.,
2004). Prior to analysis the difference in caregiving was thought to be a result of limited
resources. Perhaps the skepticism towards outsiders or strangers is also responsible for
differences in caregiving structures between populations.
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Difficulties
There were a number of challenges to overcome during implementation. The most
consistent challenge was developing trust and establishing rapport with patients quickly over the
phone. In most cases the doctoral student was the first palliative care team member to talk with
the patient. It was the doctoral student’s responsibility to create a positive first impression and
establish a relationship. It may be uncomfortable to have intimate discussions regarding health,
disease trajectory, and burden of symptoms. It can be even more uncomfortable to have such
discussions with a stranger over the phone. Therefore, it was crucial that each patient was
assured that the doctoral student was competent, trustworthy, and compassionate. At times
fostering a quality relationship was more important that receiving quality data. When patients
were resistant to providing sensitive information over the phone this hesitancy was respected.
Many patients were fatigued, distressed, and in pain. These patients have limited energy
to offer. This was a significant barrier to participation. Additionally, many patients see a
multitude of healthcare providers. Prior to provider visits patients are often required to fill out
forms and questionnaires. Repeated web-based, telephone, and paper-based questionnaires can
create survey fatigue (Olson, 2014). Providing relevance to the questionnaires and emphasizing
the importance of the information obtained was challenging but essential to encourage
participation. Still, many patients elected not to participate with the qualitative questionnaire and
the MDASI. Patients’ hesitancy to discuss personal information, the decision to decline
participation due to fatigue and distress, and the overall number of home-based referrals
contributed to the final challenge of obtaining a satisfactory sample size.
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Strengths
The midwest hospice and palliative care organization has attempted to gather quality data
in the past but had been unsuccessful for multiple reasons. This quality improvement initiative
provided the organization an opportunity to trial a symptom inventory, observe the
implementation protocol in action, and determine limitations and weaknesses prior to committing
organizational time and energy. Following the implementation the organization had an
opportunity to sustain the project or move in another direction. The organization has elected to
continue the implementation but made a few adaptations to the follow up procedures as a
response to information learned during implementation. Because of workload and logistical
concerns the organization has elected not to administer the MDASI prior to and 1-week
following medication regimen changes. The organization’s ability to make necessary
adjustments prior to adopting the protocol is a considerable strength and improves the likelihood
of sustainability and a successful implementation.
Another strength of the scholarly project is the clarity of themes noted in the qualitative
analysis of perceived barriers to palliative care. The analysis suggests patients suffer from
distressing symptoms for an extended period of time prior to obtaining a palliative care referral.
Additionally, the majority of patients did not receive palliative care services sooner because of a
knowledge gap regarding palliative care’s role and existence. This information provides urgency
for educating the community about palliative care. The knowledge gleaned from this analysis
can also guide marketing and education strategies. The questionnaire provided insights
regarding how patients learned about palliative care and what prevented patients from accessing
services sooner. The organization can utilize this information to determine what modes of
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communication are reaching patients and perhaps develop strategies to educate prospective
patients sooner.
Weaknesses
The scholarly project had a number of weaknesses. The first weakness was the number
of participants reached for the quality improvement initiative. The organization experienced an
uncharacteristically low number of community based referrals during the implementation period.
The project also experienced a large number of patients electing not to participate as well as a
large attrition rate following the first interaction. Of the 29 patients referred for symptom
management, 10 did not participate with the MDASI at consultation. Patients did not participate
with the MDASI because 1 was too weak, 1 was unable to communicate clearly over the phone,
2 were admitted to the hospital prior to consultation, 1 could not be reached despite many
attempts, 1 passed away prior to consultation, and 4 patients refused. Although 10 patients did
not participate with the MDASI, 6 of these patients completed the qualitative questionnaire or
had family answer the questions on the patient’s behalf.
A number of patients were lost to follow up after completing an initial MDASI. In all, 3
patients refused follow up surveys due to survey fatigue, 2 patients transitioned to hospice care, 2
patients deceased, and 5 patients only completed 1 MDASI because the scholarly project was
completed prior to the 1 week follow up interaction.
Lastly, another weakness of the scholarly project was the missed interactions prior to
medication regimen changes. On 2 occasions medication regimen changes were made prior to
the administration of the MDASI. On 1 occasion a patient called the weekend on call nurse
regarding a pain crisis. A medication regimen change was made over the weekend and the
doctoral student was not notified until 3 days later. On another occasion the physician spoke

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS

70

directly to the patient during a follow up interaction and made medication changes without
notifying the doctoral student. Workload concerns and logistical issues such as these scenarios
contributed to the organization’s decision not to administer the MDASI during and after
medication regimen changes.
Limitations
High attrition rates are a common occurrence when observing the palliative care
population (Visser, Hadley, & Wee, 2015). Losing patients to follow up may be inherent of
palliative care research but it is a limitation nonetheless. Improvements in MDASI scores at 1
week and 1 month can be noted compared to baseline. However, very little can be drawn
regarding the program’s effectiveness with a small sample size.
Limitations are also noted in the qualitative analysis. Question 1 of the questionnaire
asks, “How long have your symptoms affected your life?” This question was intended to
determine the amount of time a patient was appropriate for a palliative care referral prior to
obtaining services. However, Question 1 of the questionnaire does not answer this intended
question accurately. In fact, it is uncertain what can be deduced from this question. The
question does not indicate how long symptoms have been poorly controlled, how long symptoms
have interfered with daily activities, or the amount of time distressing symptoms has
compromised quality of life.
The fourth question of the perceived barriers qualitative analysis was another limitation
of the scholarly project. The final question asked the patient, “Do you believe where you live
impacted your ability to receive palliative care.” First, a significant weakness of this question is
the close-ended format. A question that can be answered with a yes or a no does not provide
means for an in depth qualitative analysis. Additionally, not a single patient believed location of
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residence impacted the ability to access palliative care. This response did little to improve the
understanding of barriers to palliative care services.
Clinical Implications
While the MDASI was moderately accepted by the organization facts for consideration
are as follows. A difficulty faced during implementation was building a rapport quickly over the
phone to make patients confortable and willing to engage with the inventory and questionnaire.
Although the doctors in the organization were resistant, the MDASI may be better received if the
physician administered the first inventory face-to-face during the consultation. When
determining who would administer the MDASI, the organization discussed the possibility of the
Social Worker to decrease the workload of the Registered Nurse. Upon further consideration,
the organization determined the clinical expertise of the Registered Nurse would improve the
symptom assessment process. The frequency of MDASI administration was another topic of
discussion. Midway through the implementation process the organization was considering
administering the MDASI at consultation and at 1 month. The doctoral student encouraged the
organization to consider administering the symptom assessment tool at 1 week as well. It was
believed that the MDASI contributed to the assessment of medication regimen effectiveness and
provided valuable follow-up information. It was also believed that administering the MDASI at
1 week standardized patient follow-up and guided medication regimen changes. Administering
the MDASI during every patient follow up is supported by literature (Ripamonti et al., 2012).
However, the organization did not believe administering the MDASI prior to medication regimen
changes and following medication regimen changes was feasible or sustainable. Following
discussions the organization decided to administer the MDASI at consultation, 1 week after
consultation, and 1 month after consultation.
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Dissemination of Outcomes
The doctoral student disseminated outcomes by presenting project results to the midwest
palliative care team. The presentation focused on referral patient characteristics, the program’s
performance of managing symptoms, and information learned regarding palliative care barriers
in rural and non-rural populations.
Conclusion
Palliative care services are provided in an assortment of settings including hospitals,
outpatient clinics, rehabilitation facilities, assisted living facilities, over the phone, and inside
patient’s homes (Meyers et al., 2014). Community-based palliative care is a comprehensive and
multidisciplinary service that follows patients across the disease trajectory though transitions of
care and a variety of healthcare settings (Kamal et al., 2013). A significant component of
palliative care and its success on patient outcomes is the ability of the team to manage distressing
symptoms (Hui et al., 2014). Unpleasant symptoms impact almost every facet of a patient’s life
and impairs functional capacity and increases patient’s distress (Carlson et al., 2012; Cleeland et
al., 2000). In order to provide high quality care symptoms must be measured regularly and
accurately (Cleeland et al., 2000). A proper symptom inventory will identify symptoms, expose
severity, and will be sensitive to detect responses from treatment (Cleeland et al., 2000).
Although no symptom inventory is perfect, the MDASI was deemed sustainable, feasible, and
was accepted by a midwest palliative care team to assess patient’s symptoms and to provide
quality measures.
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Appendix A: Theory of Unpleasant Symptoms
Theory of Unpleasant Symptoms

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS

82

Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The middle-range theory
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Used with permission. See Appendix B.

Appendix B: Theory of Unpleasant Symptoms Permission
Dear Daniel,
Your project sounds very interesting. If you plan to reproduce the figure in your project report,
that is acceptable. If you were to use it in something you would sell, then you would need

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS

83

permission from Springer Publishing Company. The publisher company holds the copyright;
Linda and I do not.
Good luck with your project.
Sincerely,
Elizabeth Lenz, PhD, RN
Professor Emeritus
The Ohio State University
Sent from my iPhone
On Mar 16, 2017, at 3:18 PM, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote:
Dr. Lenz and Dr. Pugh,
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand
Rapids, Michigan. I am emailing you to get permission to use your Theory of Unpleasant
Symptoms for my scholarly project. My project is entitled, "Acceptability of the MD Anderson
Symptom Inventory and qualitative analysis of barriers to palliative care services for rural and
non-rural populations.” For this project I am implementing the MD Anderson Symptom
Inventory in a palliative care program to create quality measures for the organization. I am also
conducting a qualitative analysis of patient perceived barriers to accessing palliative care
services. I would like permission to use the Theory of Unpleasant Symptoms as my theoretic
framework. The project will be uploaded into ScholarWorks upon completion. Thank you for
your attention and your time!
Daniel Johnson
DNP Student

Appendix C: Burke-Litwin Model of Organizational Performance and Change
Burke-Litwin Model of Organizational Performance and Change
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Burke, W. W., & Litwin, G. H. (1992). A causal model of organizational performance and
change. Journal of Management, 18(3), 523–545.
Used with permission. See Appendix D
Appendix D: Burke-Litwin Model Permission

Dear Mr. Johnson,
You have my permission to use the Burke-Litwin Model as a framework for your
organizational assessment.
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Good luck with the project.
W. Warner Burke
On Thu, Mar 16, 2017 at 3:34 PM, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote:
Dr. Burke,
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand
Rapids, Michigan. I am emailing you to get permission to use the Burke-Litwin Model of
Organizational Change for my scholarly project. My project is entitled, "Acceptability of the
MD Anderson Symptom Inventory and qualitative analysis of barriers to palliative care services
for rural and non-rural populations.” For this project I am implementing the MD Anderson
Symptom Inventory in a palliative care program to create quality measures for the
organization. I am also conducting a qualitative analysis of patient perceived barriers to
accessing palliative care services. I would like permission to use the Burke-Litwin Model of
Organizational Change as the framework to conduct an organizational assessment. The project
will be uploaded into ScholarWorks upon completion. Thank you for your attention and your
time!
Daniel Johnson
DNP Student

-W. Warner Burke, PhD
Edward Lee Thorndike Professor of Psychology and Education
Editor, Journal of Applied Behavioral Science
Box 24 Teachers College, Columbia University
525 West 120th Street
New York, NY 10027
(212) 678-3831

Appendix E: PARiHS Implementation Model Permission

Hello Daniel
Great to hear you are using PARIHS.
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As the framework is published - as long as you reference it appropriately that's fine. If you want
to reproduce one of the figures- depending on which one it is, you will have to seek agreement
from the publisher.
Regards
Jo
Jo Rycroft-Malone
Pro-Vice Chancellor, Research & Impact
Professor of Implementation & Health Services Research
Bangor University
On 16 Mar 2017, at 19:26, Daniel Johnson <johnsod3@mail.gvsu.edu> wrote:
Dr. Rycroft-Malone,
My name is Daniel Johnson and I am a DNP student at Grand Valley State University in Grand
Rapids, Michigan. I am emailing you to get permission to use the PARIHS framework for my
scholarly project. My project is entitled, "Acceptability of the MD Anderson Symptom
Inventory and qualitative analysis of barriers to palliative care services for rural and non-rural
populations.” For this project I am implementing the MD Anderson Symptom Inventory in a
palliative care program to create quality measures for the organization. I am also conducting a
qualitative analysis of patient perceived barriers to accessing palliative care services. I would
like permission to use the PARIHS framework as my implementation model. The project will be
uploaded into ScholarWorks upon completion. Thank you for your attention and your time!
Daniel Johnson
DNP Student

Appendix F: MD Anderson Symptom Inventory
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Appendix G: MD Anderson Symptom Inventory Permission
From: symptomresearch
Sent: Thursday, February 16, 2017 7:01 PM
To: 'Daniel Johnson'; symptomresearch
Subject: RE: Order Form for Department of Symptom Research Assessment Tools
Hello,
I have attached the MDASI as you requested. Please note that:
•
Your use of the MDASI is limited only to the study specified. To use the MDASI in
additional studies, you must reapply online at www.mdanderson.org/departments/prg >
Symptom Assessment Tools > The M. D. Anderson Symptom Inventory (MDASI).
•
You are permitted to reproduce the copy of the MDASI that is included with this e-mail.
However, you must not remove the copyright notice.
•
The MDASI may not be modified in any way or translated into another language without
the express written consent of the copyright holder; Charles S. Cleeland, PhD. Failure to comply
may result in legal action. Permission to alter or translate the instrument may be obtained by
contacting me at symptomresearch@mdanderson.org or by mail.
Please let me know if you have any questions. Thank you for your interest in the MDASI.
Regards,
Kristin VanHouten

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS
Appendix H: Patient Perceived Barriers Qualitative Analysis
Date________________
County____________
Patient Perceived Barriers to Palliative Care Services

1) How long have your symptoms affected your life?

2) What has kept you from receiving palliative care before now?

3) How did you learn about palliative care and what they do?

4) Do you believe where you live impacted your ability to receive palliative care?
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Appendix I: Implementation Staff Survey
Date_________
Professional’s years of hospice and palliative care experience_______
MD Anderson Symptom Inventory (MDASI) Implementation Questionnaire

1) The MDASI provided helpful information at the right time.
1
Strongly Disagree

2

3

4

Disagree

Agree

Strongly Agree

2) The MDASI contributed to the assessment of patient symptoms
1
Strongly Disagree

2

3

4

Disagree

Agree

Strongly Agree

3) The MDASI was effective in evaluating medication regimen effectiveness/patient condition
1
Strongly Disagree

2

3

4

Disagree

Agree

Strongly Agree

4) The administration and follow-up intervals of the MDASI were practical and effective for
quality patient care and monitoring
1
Strongly Disagree

2

3

4

Disagree

Agree

Strongly Agree

5) The MDASI contributed to my practice as a healthcare professional and should be sustained
1
Strongly Disagree

2

3

4

Disagree

Agree

Strongly Agree
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Appendix J: County of Residence of Palliative Care Program Referrals

Patients
by Respondents
County
County of Residence of Qualitative
Analysis
SUM of count by counties

Kent
4

Allegan
2

VanBuren
1

Ottawa
18

'
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Appendix K: Boxplot of Patient Reported Pain at Consultation
Boxplot of Pain at Consultation
Boxplot of Pain at Intial Interaction
10

MDASI 1

8

6

4

'
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Appendix L: Table of Patient Reported Pain at Consultation
Patient Reported Pain at Consult
N
15

Mean
7.93

Standard
Deviation
2.05

Minimum
4.00

Lower
Quartile
6.00

Median
9.00

Upper
Quartile
10.00

Maximum
10.00
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Appendix M: Pain Improvement Measured with MDASI
Improvement of Pain Scores at One-Week Compared to Pain at Consultation

N
7

Mean Pain
Score
Standard
Minimum
Improvement Deviation Improvement
6.00
2.52
2.00

Lower
Quartile
3.00

Median
7.00

Upper
Quartile
8.00

Maximum
8.00
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Appendix N: Fatigue, Nausea, Distress, and Interference of Enjoyment of Life Scores at
Consultation
Fatigue, Nausea, Distress, and Interference of Enjoyment of Life Scores at Consultation
Variable
Fatigue
Nausea
Distress
Enjoyment
of Life
Interference

N
19
19
19
19

Mean
Score
6.74
2.47
5.47
6.84

Standard
Lower
Deviation Minimum Quartile
2.10
3.00
5.00
2.99
0.00
0.00
3.12
1.00
2.00
3.10
0.00
5.00

Median
7.00
1.00
6.00
7.00

Upper
Quartile Maximum
8.00
10.00
4.00
10.00
8.00
10.00
10.00
10.00
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Appendix O: Improvement of MDASI Scores at 1-Week Compared to Consultation
Improvement of MDASI Scores at 1-Week Compared to Consultation
Variable

N

Mean

Standard
Deviation

Minimum

Lower
Quartile

Median

Upper
Quartile

Maximum

Pain

6

2.67

1.97

1.00

1.00

2.00

4.00

6.00

Fatigue

6

1.17

4.17

-4.00

-2.00

0.50

5.00

7.00

Nausea

6

1.00

5.37

-6.00

-2.00

0.50

3.00

10.00

Disturbed
Sleep

6

0.83

5.31

-5.00

-5.00

1.00

6.00

7.00

Distress

6

0.50

5.36

-5.00

-5.00

0.50

3.00

9.00

Enjoyment
of Life
Interference

6

0.67

3.88

-5.00

-2.00

1.00

3.00

6.00

98

ACCEPTABILITY OF THE MDASI AND ANALYSIS OF BARRIERS

Appendix P: Improvement of MDASI Scores at 1-Month Compared to Consultation
Improvement of MDASI Scores at 1-Month Compared to Consultation
Standard
Deviation

Minimum

Lower
Quartile

Median

Upper
Quartile

Maximum

3.50

1.22

2.00

3.00

3.00

5.00

5.00

6

1.67

1.51

0.00

1.00

1.00

3.00

4.00

Nausea

6

0.83

2.56

-1.00

-1.00

-0.50

3.00

5.00

Disturbed
Sleep

6

3.00

4.00

0.00

0.00

1.00

7.00

9.00

Distress

6

0.83

5.88

-6.00

-4.00

0.00

6.00

9.00

Enjoyment
of Life
Interference

6

2.00

2.76

-1.00

0.00

1.50

4.00

6.00

Variable

N Mean

Pain

6

Fatigue
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Appendix Q: Frequency of MDASI Administration for Patients Referred Prior to March 16
Frequency of MDASI Administration for Patients Referred Prior to March 16
Number of
Administrations
1
2
3
4
5

Number
of Patients
10
8
6
4
1
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Appendix R: Time to Administer MDASI
Time to Administer MDASI in Minutes
N
38

Mean
6:27

Standard
Deviation Minimum
2:20
3:01

First
Quartile
4:32

Median
5:55

First
Quartile
8:22

Maximum
11:25
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Appendix S: Implementation Staff Survey Responses
Means and Standard Deviations of Staff Responses to Implementation Survey
Mean Score for Staff Evaluations
4

score (Mean)

3

2

1

0
Q1

Q2

Q3

Q4

label
score (Mean), 95% Confidence Limits

'

Q5
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Appendix T: IRB Approval

DATE:
TO:
FROM:
STUDY TITLE:
and

February 13, 2017
Daniel Johnson, BS, BSN
Grand Valley State University Human Research Review Committee
[1028150-2] Acceptability of the MD Anderson Symptom Inventory

qualitative analysis of barriers to palliative care services for rural and nonrural populations
REFERENCE #:
17-142-H
SUBMISSION TYPE:
New Project
ACTION:
NOT
RESEARCH EFFECTIVE DATE:
February 13,
2017
REVIEW TYPE:
Administrative Review
Thank you for your submission of materials for your planned research study. It has been determined
that this project:
Does not meet the definition of covered human subjects research* according to current federal
regulations. The project, therefore, does not require further review and approval by the HRRC.
Any research-related problem or event resulting in a fatality or hospitalization requires immediate
notification to the Human Research Review Committee Chair, Dr. Steve Glass, (616)331-8563
AND Human Research Protections Administrator, Dr. Jeffrey Potteiger, Office of Graduate
Studies (616)331-7207. See HRRC policy 1020, Unanticipated problems and adverse events.
Exempt research studies are eligible for audits.
If you have any questions, please contact the Office of Research Integrity and Compliance at (616)
331-3197 or rci@gvsu.edu. The office observes all university holidays, and does not process
applications during exam week or between academic terms. Please include your study title and
reference number in all correspondence with our office.
*Research is a systematic investigation, including research development, testing and
evaluation, designed to develop or contribute to generalizable knowledge (45 CFR 46.102 (d)).
Human subject means a living individual about whom an investigator (whether professional or student)
conducting research obtains: data through intervention or interaction with the individual, or identifiable
private information (45 CFR 46.102 (f)).
Scholarly activities that are not covered under the Code of Federal Regulations should not be
described or referred to as research in materials to participants, sponsors or in dissemination of
findings.
Research Protections Program | 1 Campus Drive | 049 James H Zumberge Hall | Allendale, MI 49401 Ph
616.331.3197 | rpp@gvsu.edu | www.gvsu.edu/rpp

